anthralin has been researched along with Palmoplantaris Pustulosis in 561 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combination of narrow-band UVB (311 nm) therapy with calcitriol is equally effective as the combination with dithranol for the treatment of psoriasis." | 9.10 | Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. ( Bröcker, EB; Eggert, AA; Goebeler, M; Hofmann, UB, 2003) |
| " Twenty-two inpatients with active plaque psoriasis received topical treatment with 5% salicylic acid ointment, 0." | 9.10 | Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients. ( Borawska, M; Chodynicka, B; Hukalowicz, K; Mysliwiec, H; Porebski, P; Serwin, AB, 2003) |
| "In a multicenter study 210 patients with moderate to severe chronic plaque-type psoriasis were randomly assigned to treatment with cyclosporine or etretinate." | 9.08 | Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. ( Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G, 1995) |
| "Fifty patients with psoriasis undergoing a standard Ingram regime were entered into a double-blind comparison of oral indomethacin and placebo." | 9.07 | The effect of oral indomethacin on psoriasis treated with the Ingram regime. ( Goodfield, MJ; Rowell, NR; Sheehan-Dare, RA, 1991) |
| "Twenty patients with chronic plaque psoriasis were treated with short-contact anthralin followed by 10% triethanolamine application to one side of the body and aqueous cream to the other." | 9.06 | The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis. ( Bruce, JM; Lawrence, CM; Ramsay, B; Shuster, S, 1990) |
| "An open clinical trial was carried out using butantrone ointment in the treatment of 10 patients with psoriasis in order to assess staining and irritation in relation to efficacy." | 9.06 | Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis. ( Greaves, MW, 1986) |
| "0125% clobetasol propionate in the treatment of chronic plaque psoriasis was undertaken." | 9.06 | Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. ( Clement, MI; du Vivier, A; Hehir, ME; Monk, BE; Pembroke, AC, 1988) |
| "The influence of short-contact anthralin on the therapeutic effect of ultraviolet B irradiation (Sylvania UV-21 tubes) was investigated with the half-body comparison method in fifteen outpatients with plaque-type psoriasis." | 9.06 | Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis. ( Boer, J; Smeenk, G, 1986) |
| "A short term anthralin application schedule was used at home in 42 patients with severe psoriasis." | 9.05 | Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses. ( Brun, P; Juhlin, L; Schalla, W, 1984) |
| "Anthralin is an effective topical drug for psoriasis therapy." | 9.05 | Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. ( Ashton, RE; Koudsi, H; Lowe, NJ; Schaefer, H; Verschoore, M, 1984) |
| "We present a new method for the outpatient use of anthralin paste in the treatment of psoriasis." | 9.05 | Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis. ( Burns, J; Cannon, TC; Engelhard, CS; Pearlman, DL, 1984) |
| "Recent trends in psoriasis therapy favor using lower-strength anthralins." | 9.05 | The effectiveness of low-strength anthralin in psoriasis. A paired comparison study. ( Dawkins, L; Hernandez, AD; Josephs, JA; Marley, WM, 1982) |
| "There had been recent interest in psoriasis treatment regimens with low anthralin concentrations of 0." | 9.05 | Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis. ( Breeding, J; Lowe, NJ, 1981) |
| "Antipsoriatic anthrones are probably the most commonly used topical agents in the treatment of psoriasis." | 8.79 | Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives. ( Müller, K; Wiegrebe, W, 1995) |
| "In a survey of clinical trials concerning the efficacy of short-contact therapy with anthralin in psoriasis vulgaris, focusing principally on methodologic issues, twenty-four papers published between January 1982 and December 1989, in English, French, and Italian, were selected." | 8.78 | Development of anthralin short-contact therapy in psoriasis: survey of published clinical trials. ( Cainelli, T; Carrel, CF; D'Oro, LC; Naldi, L; Parazzini, F, 1992) |
| "Dithranol (anthralin) is one of the basic compounds used in the treatment of psoriasis vulgaris." | 8.77 | [Urea in combination with dithranol in treating psoriasis vulgaris]. ( Bieber, K; Kaudewitz, P; Przybilla, B, 1989) |
| "Evidence on effectiveness and safety of methotrexate (MTX) in pediatric psoriasis is scarce." | 7.81 | Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry. ( de Jong, EM; Hendriks, JC; Hoppenreijs, EP; Oostveen, AM; Seyger, MM; van de Kerkhof, PC; van Geel, MJ, 2015) |
| "Anthralin is a widely used topical anti-psoriatic drug that may have an immunomodulating effect on alopecia areata (AA) as it does in psoriasis." | 7.72 | Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. ( Cao, L; Lui, H; Shapiro, J; Sundberg, JP; Tang, L, 2004) |
| "In order to determine the usefulness of anthralin in the treatment of psoriasis, we evaluated the effectiveness of topical anthralin therapy in patients with psoriasis vulgaris in our hospital." | 7.70 | Topical anthralin for psoriasis vulgaris: evaluation of 70 Japanese patients. ( Irimajiri, J; Matsuuchi, M; Nishioka, K; Otoyama, K; Yamamoto, T, 2000) |
| "We investigated whether topical anthralin would augment clearing of psoriasis produced by systemic cyclosporine." | 7.69 | Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study. ( Gilleaudeau, P; Gottlieb, AB; Gottlieb, SL; Heftler, NS; Johnson, R; Krueger, JG; Vallat, VP; Wolfe, J, 1995) |
| "Rapid clearing of psoriasis in a psoriasis treatment center setting has been obtained with a combination of short-contact coal tar, phototherapy from high-pressure metal halide lamps (consisting of UVA and UVB), and short-contact high-potency anthralin therapy." | 7.68 | UVABA therapy for psoriasis. Efficacy with shortened treatment times with the combined use of coal tar, anthralin, and metal halide ultraviolet machines. ( Lowe, NJ; Swinehart, JM, 1991) |
| "Previous studies have shown that when butantrone and dithranol were used in equimolar gradually increasing concentrations in short-contact therapy for psoriasis the efficacy of butantrone was somewhat lower compared to dithranol." | 7.67 | Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol). ( Remitz, A, 1989) |
| "Anthralin therapy was used in 39 cases with psoriasis, 31 cases with large plaque type and 8 cases with small plaque type." | 7.67 | [Anthralin therapy of psoriasis--a retrospective study of 39 cases]. ( Higashi, K; Katayama, I; Nishioka, K; Nishiyama, S, 1989) |
| "In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured." | 7.67 | [Urea and urea combinations in psoriasis]. ( Rohde, BT, 1989) |
| "Mast cell degranulation (MCD) was studied in lesions of chronic psoriasis vulgaris before and during topical treatment with low-strength anthralin." | 7.67 | Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study. ( Brody, I, 1986) |
| "The effect of tar on anthralin-induced erythema was epicutaneously tested in ten patients." | 7.67 | [Effect of various kinds of tar and tar concentrations on anthralin erythema]. ( Mahrle, G; Schulze, HJ; Steigleder, GK; Wemmer, U, 1986) |
| "Eighteen patients with chronic plaque psoriasis were investigated in two groups to determine the optimal contact time for the application of 2% anthralin, within the range immediate removal to removal at 20 min." | 7.67 | Short contact anthralin in the treatment of psoriasis: a study of different contact times. ( MacDonald, KJ; Marks, J, 1986) |
| "Anthralin is effective in the management of psoriasis." | 7.67 | Anthralin cream as short contact therapy for psoriasis. ( Miller, AC, 1985) |
| "Anthralin erythema dose-response curves were drawn for thirty adult patients of various skin types who had chronic plaque psoriasis." | 7.66 | Relationship between skin type and erythemal response to anthralin. ( Greaves, MW; Maurice, PD, 1983) |
| "Anthralin has been applied in low and high concentrations with and without UV-irradiation in the treatment of psoriasis (Schauder & Mahrle, 1982a,b)." | 7.66 | Anthralin inflammation versus UV-erythema in psoriatics. ( Mahrle, G; Schauder, S, 1983) |
| "Thirty-six patients with psoriasis were treated with short-term application of anthralin in three studies." | 7.66 | Measurement of the response of psoriasis to short-term application of anthralin. ( Coburn, PR; Marks, J; Marsden, JR; Shuster, S, 1983) |
| "Fifty-one patients with psoriasis were treated with 1% anthralin for 1 h (1-h treatment) and UV-light." | 7.66 | [Combined 1-hour therapy of psoriasis using anthralin and UV light]. ( Mahrle, G; Schauder, S, 1982) |
| "A total of 66 patients with psoriasis was treated with one percent anthralin for one hour (one-hour-treatment) and UV-light." | 7.66 | [One-hour-treatment of psoriasis with anthralin and UV-light (author's transl)]. ( Mahrle, G; Schauder, S, 1982) |
| "New found knowledge concerning the penetration kinetics of anthralin induced us to modify the treatment of psoriasis." | 7.66 | [A very promising treatment method in psoriasis. Short-term anthralin therapy]. ( Kunze, J; Petres, J, 1981) |
| "The topical treatment of active chronic psoriasis can be achieved as effectively with 0,1% dithranol + 17% urea as with triamcinolone acetonite 0,1%." | 7.66 | [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)]. ( Ernst, TM, 1981) |
| "The activity of ICDH(NAD) was measured in subcorneal and basal epidermal layers in 8 patients with psoriasis and in 7 healthy controls treated once a day with 0." | 7.65 | Epidermal activity of NAD-dependent isocitrate dehydrogenase in psoriasis during treatment with dithranol. ( Hammar, H, 1975) |
| "Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0." | 6.69 | A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998) |
| " Safety was determined from reports of adverse events and blood chemistry analysis." | 6.69 | The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. ( Hutchinson, PE; Marks, R; White, J, 2000) |
| "Butantrone has an antipsoriatic activity almost equal to that of dithranol." | 6.66 | Comparison of dithranol and butantrone in short contact therapy of psoriasis. ( Göransson, A, 1987) |
| "Psoriasis is difficult to manage in general practice, mainly because the standard treatments produce side effects, or are ineffective in both the short and long term." | 6.66 | Low concentration dithranol and coal tar (Psorin) in psoriasis: a comparison with alcoholic coal tar extract and allantoin (Alphosyl). ( Harrington, CI, 1989) |
| "Patients with untreated, active psoriasis had increased chemotactic response of their monocytes and neutrophils to N-formyl-methionyl-leucyl-phenylalanine." | 5.27 | The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin. ( Ternowitz, T, 1987) |
| "The aim of the study was to examine the effectiveness of the oxidized form of nicotinamide adenine dinucleotide (NAD(+)), adenosine precursor, in 37 patients suffering from psoriasis." | 5.12 | In search for new antipsoriatic agents: NAD topical composition. ( Adamus, J; Gebicki, J; Sysa-Jedrzejowska, A; Szajerski, P; Wozniacka, A, 2007) |
| " It was tested whether this binding abnormality is specific for psoriasis and the effects of treatment were compared with etretinate, cyclosporine A, or anthralin on 2-(3)H-8-N(3)-cyclic adenosine monophosphate binding to the regulatory subunit of protein kinase A in erythrocyte membranes." | 5.10 | A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. ( Benes, P; Benz, RE; Färber, L; Langendorf, Y; Schopf, RE, 2002) |
| "Combination of narrow-band UVB (311 nm) therapy with calcitriol is equally effective as the combination with dithranol for the treatment of psoriasis." | 5.10 | Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. ( Bröcker, EB; Eggert, AA; Goebeler, M; Hofmann, UB, 2003) |
| " Twenty-two inpatients with active plaque psoriasis received topical treatment with 5% salicylic acid ointment, 0." | 5.10 | Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients. ( Borawska, M; Chodynicka, B; Hukalowicz, K; Mysliwiec, H; Porebski, P; Serwin, AB, 2003) |
| "Dithranol (anthralin) has been known to be effective in the treatment of psoriasis for more than 80 years." | 5.09 | The influence of a topical corticosteroid on short-contact high-dose dithranol therapy. ( Gerritsen, MJ; Prins, M; Swinkels, OQ; Tosserams, EF; Van De Kerkhof, PC; Van Der Valk, PG, 2001) |
| "In a multicenter study 210 patients with moderate to severe chronic plaque-type psoriasis were randomly assigned to treatment with cyclosporine or etretinate." | 5.08 | Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. ( Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G, 1995) |
| "Short-contact treatment with dithranol (anthralin) is a widely used treatment for chronic plaque psoriasis." | 5.07 | A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. ( Berth-Jones, J; Chu, AC; Dodd, WA; Ganpule, M; Griffiths, WA; Haydey, RP; Jurgensen, HJ; Klaber, MR; Murray, SJ; Rogers, S, 1992) |
| "Epidermal calmodulin (CaM) levels were measured in the involved and uninvolved skin in 26 psoriasis patients before and after treatment either with dithranol topically or methotrexate orally." | 5.07 | Epidermal calmodulin levels in psoriasis before & after therapy. ( Ganguly, NK; Garg, J; Kaur, I; Kaur, S; Kohli, M; Vaishnavi, C, 1991) |
| "Fifty patients with psoriasis undergoing a standard Ingram regime were entered into a double-blind comparison of oral indomethacin and placebo." | 5.07 | The effect of oral indomethacin on psoriasis treated with the Ingram regime. ( Goodfield, MJ; Rowell, NR; Sheehan-Dare, RA, 1991) |
| "Twenty patients with chronic plaque psoriasis were treated with short-contact anthralin followed by 10% triethanolamine application to one side of the body and aqueous cream to the other." | 5.06 | The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis. ( Bruce, JM; Lawrence, CM; Ramsay, B; Shuster, S, 1990) |
| "An open clinical trial was carried out using butantrone ointment in the treatment of 10 patients with psoriasis in order to assess staining and irritation in relation to efficacy." | 5.06 | Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis. ( Greaves, MW, 1986) |
| "Twenty four of 30 patients with chronic plaque psoriasis completed a double-blind randomized paired comparison of dithranol in Lassar's paste versus dithranol and fluocinonide in Lassar's paste." | 5.06 | Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis. ( Christopher, AP; Cowan, MA; Grattan, CE; Robinson, M, 1988) |
| "0125% clobetasol propionate in the treatment of chronic plaque psoriasis was undertaken." | 5.06 | Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. ( Clement, MI; du Vivier, A; Hehir, ME; Monk, BE; Pembroke, AC, 1988) |
| "The influence of short-contact anthralin on the therapeutic effect of ultraviolet B irradiation (Sylvania UV-21 tubes) was investigated with the half-body comparison method in fifteen outpatients with plaque-type psoriasis." | 5.06 | Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis. ( Boer, J; Smeenk, G, 1986) |
| "A short term anthralin application schedule was used at home in 42 patients with severe psoriasis." | 5.05 | Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses. ( Brun, P; Juhlin, L; Schalla, W, 1984) |
| "Anthralin is an effective topical drug for psoriasis therapy." | 5.05 | Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. ( Ashton, RE; Koudsi, H; Lowe, NJ; Schaefer, H; Verschoore, M, 1984) |
| "We present a new method for the outpatient use of anthralin paste in the treatment of psoriasis." | 5.05 | Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis. ( Burns, J; Cannon, TC; Engelhard, CS; Pearlman, DL, 1984) |
| "Recent trends in psoriasis therapy favor using lower-strength anthralins." | 5.05 | The effectiveness of low-strength anthralin in psoriasis. A paired comparison study. ( Dawkins, L; Hernandez, AD; Josephs, JA; Marley, WM, 1982) |
| "There had been recent interest in psoriasis treatment regimens with low anthralin concentrations of 0." | 5.05 | Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis. ( Breeding, J; Lowe, NJ, 1981) |
| "The rate of relapse after dithranol therapy is significantly less that when betamethasone valerate under occlusion is combined with ditrhanol in the treatment of psoriasis." | 5.04 | Relapse rate of psoriasis worsened by adding steroids to a dithranol regime. ( Seville, RH, 1976) |
| "Anthralin has been a consistently effective drug for the treatment of psoriasis for more than 80 years, but has not enjoyed common use in the United States because of the unwanted side effects of irritation and staining." | 4.80 | Old wine in new bottles: the revival of anthralin. ( Harris, DR, 1998) |
| "Antipsoriatic anthrones are probably the most commonly used topical agents in the treatment of psoriasis." | 4.79 | Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives. ( Müller, K; Wiegrebe, W, 1995) |
| "Anthralin is among the most effective agents for the topical treatment of psoriasis." | 4.79 | Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals. ( Müller, K, 1997) |
| " In patients with chronic plaque psoriasis involved in short term studies of 6 to 8 weeks' duration, calcipotriol ointment applied twice daily was significantly more effective than betamethasone valerate and dithranol (anthralin)." | 4.78 | Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. ( Clissold, SP; Murdoch, D, 1992) |
| "In a survey of clinical trials concerning the efficacy of short-contact therapy with anthralin in psoriasis vulgaris, focusing principally on methodologic issues, twenty-four papers published between January 1982 and December 1989, in English, French, and Italian, were selected." | 4.78 | Development of anthralin short-contact therapy in psoriasis: survey of published clinical trials. ( Cainelli, T; Carrel, CF; D'Oro, LC; Naldi, L; Parazzini, F, 1992) |
| "Dithranol (anthralin) is one of the basic compounds used in the treatment of psoriasis vulgaris." | 4.77 | [Urea in combination with dithranol in treating psoriasis vulgaris]. ( Bieber, K; Kaudewitz, P; Przybilla, B, 1989) |
| "Drugs that have been associated with the precipitation or exacerbation of psoriasis include lithium, beta adrenergic receptor blocking agents, and antimalarials." | 4.77 | Drugs in exacerbation of psoriasis. ( Abel, EA; DiCicco, LM; Farber, EM; Fraki, JE; Orenberg, EK, 1986) |
| " In the management of psoriasis, PUVA plus retinoids, PUVA plus methotrexate and PUVA plus UVB phototherapy are the most frequently used combinations." | 4.77 | PUVA combination therapy. ( Morison, WL, 1985) |
| "Current concepts in the treatment of psoriasis are reviewed, including: traditional modalities of dithranol (anthralin), tar, and corticosteroids alone or in combination with other agents; phototherapy and photochemotherapy; experimental studies with the aromatic retinoid etretinate and related analogues; dialysis; and the potential use of hyperthermia." | 4.76 | Psoriasis. A review of recent advances in treatment. ( Farber, EM; Nall, L, 1984) |
| "Retinoids are effective in all forms of psoriasis and can be used alone or in combination with other therapeutic measures (anthralin, corticoids, PUVA, SUP)." | 4.76 | [Psoriasis therapy with retinoid]. ( Lubach, D; Marghescu, S; Rudolph, PO, 1982) |
| "This study aims to unravel the direct effects of anthralin on keratinocyte proliferation, differentiation and production of psoriasis-associated factors." | 3.85 | Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes. ( Brück, J; Carevic, M; Eberle, FC; Fehrenbacher, B; Ghoreschi, K; Holstein, J; Müller-Hermelink, E; Schäfer, I; Schaller, M; Schittek, B, 2017) |
| "Evidence on effectiveness and safety of methotrexate (MTX) in pediatric psoriasis is scarce." | 3.81 | Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry. ( de Jong, EM; Hendriks, JC; Hoppenreijs, EP; Oostveen, AM; Seyger, MM; van de Kerkhof, PC; van Geel, MJ, 2015) |
| "Even though anthralin is a well-established topical therapeutic agent for psoriasis, little is known about its effects and biochemical mechanisms of signal transduction." | 3.72 | Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation. ( Beyerle, A; Meves, A; Peus, D; Pittelkow, MR; Pott, M; Vasa, M, 2004) |
| "Anthralin is a widely used topical anti-psoriatic drug that may have an immunomodulating effect on alopecia areata (AA) as it does in psoriasis." | 3.72 | Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. ( Cao, L; Lui, H; Shapiro, J; Sundberg, JP; Tang, L, 2004) |
| "Broad-band UVB alone or in combination with different topical drugs (anthralin, calcipotriol), systemic PUVA and bath-PUVA therapy are very effective and well-established treatment modalities for psoriasis." | 3.71 | Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches. ( Ackermann, G; Eholzer, C; Karrer, S; Landthaler, M; Szeimies, RM, 2001) |
| "Anthralin is a safe, effective treatment for psoriasis, but its efficacy is hampered by the side-effects of irritation and staining of the uninvolved skin." | 3.70 | The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration. ( Friedmann, PS; Parslew, R, 1999) |
| "Anthralin is a widely used, topical therapy for psoriasis." | 3.70 | Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes. ( Beyerle, A; Meves, A; Peus, D; Pittelkow, MR; Pott, M; Rittner, HL; Weyand, C, 2000) |
| "In order to determine the usefulness of anthralin in the treatment of psoriasis, we evaluated the effectiveness of topical anthralin therapy in patients with psoriasis vulgaris in our hospital." | 3.70 | Topical anthralin for psoriasis vulgaris: evaluation of 70 Japanese patients. ( Irimajiri, J; Matsuuchi, M; Nishioka, K; Otoyama, K; Yamamoto, T, 2000) |
| "We investigated whether topical anthralin would augment clearing of psoriasis produced by systemic cyclosporine." | 3.69 | Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study. ( Gilleaudeau, P; Gottlieb, AB; Gottlieb, SL; Heftler, NS; Johnson, R; Krueger, JG; Vallat, VP; Wolfe, J, 1995) |
| "Anthralin is still the most effective and safest therapeutic agent for treatment of psoriasis." | 3.69 | Anthralin: how does it act and are there more favourable derivatives? ( Bonnekoh, B; Hegemann, L; Mahrle, G; Wevers, A, 1994) |
| "Interleukin-8 is assumed to play a central role in the pathogenesis of psoriasis." | 3.69 | The interleukin-8 receptor: a potential target for antipsoriatic therapy? ( Dobozy, A; Farkas, B; Kemény, L; Kenderessy, AS; Michel, G; Olasz, E; Ruzicka, T, 1994) |
| "Anthralin is one of the most effective and safest therapeutic agents for the treatment of psoriasis, a skin disease characterized by epidermal hyperproliferation and hyperkeratosis." | 3.69 | Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes. ( Baeuerle, PA; Packer, L; Podda, M; Schmidt, KN, 1996) |
| "Anthralin is an effective topical treatment for active psoriasis; however, its mechanism of action is unknown." | 3.68 | Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro. ( Ashinoff, R; Gottlieb, AB; Khandke, L; Krane, JF; Krueger, JG; Staiano-Coico, L, 1992) |
| "Three biopsies of normal skin and 15 biopsies collected from patients with psoriasis vulgaris were analyzed for the expression of the 50 kd cytokeratin using direct immunofluorescence and ABC technique before and after local treatment with anthralin 0." | 3.68 | Immunohistochemical study on the pattern of 50 kd cytokeratin in psoriasis. ( Fedi, AM; Leoncini, P; Lotti, T; Meo, AL; Rizzo, A, 1992) |
| "Rapid clearing of psoriasis in a psoriasis treatment center setting has been obtained with a combination of short-contact coal tar, phototherapy from high-pressure metal halide lamps (consisting of UVA and UVB), and short-contact high-potency anthralin therapy." | 3.68 | UVABA therapy for psoriasis. Efficacy with shortened treatment times with the combined use of coal tar, anthralin, and metal halide ultraviolet machines. ( Lowe, NJ; Swinehart, JM, 1991) |
| " In the present study, however, 36 psoriasis blood sera were examined before and fourteen days after the coal tar and dithranol (anthralin, cignolin) therapy onset to determine D and E fibrinogen fragments." | 3.68 | [Effect of tar and dithranol on fibrinolysis in treatment of psoriasis]. ( Arenberger, P; Buchtová, L, 1990) |
| " Cutaneous fibrinolytic activity (dependent on the activity of UK and tPA) was studied with the autohistographic fibrin film method in 40 patients affected by psoriasis vulgaris before and after topical (anthralin, betamethasone valerate, hydrocolloid occlusive dressing) or systemic psoralen-ultraviolet-light (PUVA) treatments." | 3.68 | Antipsoriatic therapies inhibit epidermal plasminogen activator activity. ( Bonan, P; Cannarozzo, G; Fedi, AM; Lotti, T; Panconesi, E, 1990) |
| "Anthralin is an extremely effective, nontoxic treatment for psoriasis." | 3.68 | Practical aspects of anthralin therapy. ( Fiore, M, 1990) |
| "A group of forty-eight patients with psoriasis who were being treated with anthralin cream were examined for side effects." | 3.67 | Toxicologic study of anthralin in an aqueous cream formulation. ( Bugrein, A; Coulson, IH; Greaves, MW; Neill, SM, 1984) |
| "The inflammatory dose-response to topical anthralin and whole skin aryl hydrocarbon hydroxylase (AHH) activity were measured before and 24 h after application of a coal tar solution to the uninvolved skin of patients with psoriasis." | 3.67 | Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy. ( Finnen, MJ; Lawrence, CM; Shuster, S, 1984) |
| "Previous studies have shown that when butantrone and dithranol were used in equimolar gradually increasing concentrations in short-contact therapy for psoriasis the efficacy of butantrone was somewhat lower compared to dithranol." | 3.67 | Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol). ( Remitz, A, 1989) |
| "Anthralin therapy was used in 39 cases with psoriasis, 31 cases with large plaque type and 8 cases with small plaque type." | 3.67 | [Anthralin therapy of psoriasis--a retrospective study of 39 cases]. ( Higashi, K; Katayama, I; Nishioka, K; Nishiyama, S, 1989) |
| "In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured." | 3.67 | [Urea and urea combinations in psoriasis]. ( Rohde, BT, 1989) |
| "The pros and cons concerning the involvement of arachidonic acid metabolism in the pathogenesis of psoriasis are presented." | 3.67 | [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis]. ( Ruzicka, T, 1985) |
| "Anthralin inflammatory oedema was measured using Harpenden calipers on psoriatic plaque and clinically uninvolved skin 6-48 h after anthralin application." | 3.67 | Time course and intensity of anthralin inflammation on involved and uninvolved psoriatic skin. ( Lawrence, CM; Paramsothy, Y, 1987) |
| "In 44 patients with chronic plaque psoriasis anthralin therapy was used as high-strength short-contact therapy in a bilateral comparison of anthralin versus 5% crude coal tar-anthralin combination." | 3.67 | Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy. ( Mahrle, G; Schauder, S; Schulze, HJ; Steigleder, GK, 1987) |
| "Mast cell degranulation (MCD) was studied in lesions of chronic psoriasis vulgaris before and during topical treatment with low-strength anthralin." | 3.67 | Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study. ( Brody, I, 1986) |
| "The effect of tar on anthralin-induced erythema was epicutaneously tested in ten patients." | 3.67 | [Effect of various kinds of tar and tar concentrations on anthralin erythema]. ( Mahrle, G; Schulze, HJ; Steigleder, GK; Wemmer, U, 1986) |
| "Application of 1% potassium hydroxide (KOH) reduced subsequent development of anthralin inflammation without loss of its therapeutic effect on psoriasis." | 3.67 | Reduction of anthralin inflammation by potassium hydroxide and Teepol. ( Bruce, JM; Collins, M; Lawrence, CM; Shuster, S, 1987) |
| "Free anthralin was detected in the stratum corneum and in hair follicles in histological sections of patients with psoriasis undergoing short contact therapy." | 3.67 | Detection of anthralin in skin during treatment. ( Juhlin, L; Schroot, B, 1985) |
| "Eighteen patients with chronic plaque psoriasis were investigated in two groups to determine the optimal contact time for the application of 2% anthralin, within the range immediate removal to removal at 20 min." | 3.67 | Short contact anthralin in the treatment of psoriasis: a study of different contact times. ( MacDonald, KJ; Marks, J, 1986) |
| "Anthralin is effective in the management of psoriasis." | 3.67 | Anthralin cream as short contact therapy for psoriasis. ( Miller, AC, 1985) |
| " In addition to application of anthralin, eleven patients suffering from psoriasis vulgaris have been treated by means of this cabinet equipped with 40 UV-B lamps (Sylvania STF 756085 W UV 6)." | 3.67 | [A new UV-B irradiation unit. Experiences with psoriasis vulgaris with low dosage UV-B irradiation and local cignoline use]. ( Dorn, M; Galosi, A; Przybilla, B, 1985) |
| "A new wax formulation of anthralin was compared with anthralin as used in the Ingram regimen for the treatment of chronic discoid psoriasis." | 3.66 | A novel wax stick preparation of anthralin. ( Chalmers, RJ; Marks, JM; Shuster, S, 1982) |
| "Anthralin erythema dose-response curves were drawn for thirty adult patients of various skin types who had chronic plaque psoriasis." | 3.66 | Relationship between skin type and erythemal response to anthralin. ( Greaves, MW; Maurice, PD, 1983) |
| "Symmetric lesions of ten psoriasis patients were treated with anthralin and a combination of anthralin and steroid to compare the effect of these two therapies." | 3.66 | [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid]. ( Gloor, M; Graf, R; Landau, M; Wirth, H, 1983) |
| "The so called "minutes" therapy is a fundamental new method of psoriasis treatment with dithranol (anthralin)." | 3.66 | [Psoriasis: the clinical use of "minute therapy" with Cignolin]. ( Kunze, J; Runne, U, 1983) |
| "Within a clinical study, 12 patients suffering from generalized psoriasis were treated with 0,4% anthralin ointment, unilaterally applicated in combination with UV-B-therapy." | 3.66 | [Study on the efficacy of a combined treatment of psoriasis with dithranol and UV-B (selective ultraviolet-phototherapy)]. ( Elbracht, C; Landes, E, 1983) |
| "Anthralin has been applied in low and high concentrations with and without UV-irradiation in the treatment of psoriasis (Schauder & Mahrle, 1982a,b)." | 3.66 | Anthralin inflammation versus UV-erythema in psoriatics. ( Mahrle, G; Schauder, S, 1983) |
| "Thirty-six patients with psoriasis were treated with short-term application of anthralin in three studies." | 3.66 | Measurement of the response of psoriasis to short-term application of anthralin. ( Coburn, PR; Marks, J; Marsden, JR; Shuster, S, 1983) |
| "Fifty-one patients with psoriasis were treated with 1% anthralin for 1 h (1-h treatment) and UV-light." | 3.66 | [Combined 1-hour therapy of psoriasis using anthralin and UV light]. ( Mahrle, G; Schauder, S, 1982) |
| "A total of 66 patients with psoriasis was treated with one percent anthralin for one hour (one-hour-treatment) and UV-light." | 3.66 | [One-hour-treatment of psoriasis with anthralin and UV-light (author's transl)]. ( Mahrle, G; Schauder, S, 1982) |
| "New found knowledge concerning the penetration kinetics of anthralin induced us to modify the treatment of psoriasis." | 3.66 | [A very promising treatment method in psoriasis. Short-term anthralin therapy]. ( Kunze, J; Petres, J, 1981) |
| "Advances in the treatment of psoriasis with anthralin are presented, including the suitability and acceptability of the base, the use of varying strengths of anthralin to suit the prevailing circumstances, and the need for showers or baths to control the treatment response." | 3.66 | Advances in the use of anthralin. ( Seville, RH, 1981) |
| "The topical treatment of active chronic psoriasis can be achieved as effectively with 0,1% dithranol + 17% urea as with triamcinolone acetonite 0,1%." | 3.66 | [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)]. ( Ernst, TM, 1981) |
| "Cell mediated immune reactivity was studied in eighty-five psoriasis patients and twenty-five healthy controls by an improved (quantitative) method for measuring contact hypersensitivity to 2,4 dinitrochlorobenzene (DNCB)." | 3.66 | Impaired contact hypersensitivity in untreated psoriasis and the effects of photochemotherapy and dithranol/UV-B. ( Friedmann, PS; Moss, C; Shuster, S, 1981) |
| "Numerous laboratory parameters were examined 235 patients with generalized psoriasis treated orally with retinoid and in 35 patients treated topically with anthralin as control." | 3.66 | Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment. A multicenter study of computerized data. ( Goerz, G; Happle, R; Hofbauer, M; Landes, E; Mahrle, G; Orfanos, CE; Schimpf, A, 1979) |
| "The activity of ICDH(NAD) was measured in subcorneal and basal epidermal layers in 8 patients with psoriasis and in 7 healthy controls treated once a day with 0." | 3.65 | Epidermal activity of NAD-dependent isocitrate dehydrogenase in psoriasis during treatment with dithranol. ( Hammar, H, 1975) |
| "This review deals with the biochemical-pharmacological actions of anthralin (dithranol) and with the various possibilities of regulating the disturbed metabolism in psoriasis." | 3.65 | [Antipsoriatic effect of dithranol (anthralin). 1]. ( Raab, W, 1975) |
| "Treatment of plaque-type psoriasis with laser in combination with topical treatment is a safe and effective therapy." | 2.77 | Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol. ( Bodendorf, MO; Grunewald, S; Kauer, F; Paasch, U; Rogalski, C; Schetschorke, M; Simon, JC, 2012) |
| "Calcipotriol has become a first-line treatment for psoriasis." | 2.72 | A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting. ( Damstra, R; de Rie, MA; de Vries, HJ; de Waard-van der Spek, FB; Haertlein, NG; Hol, CW; Kucharekova, M; Kunkeler, AC; Lijnen, RL; Oranje, AP; Swinkels, OQ; van de Kerkhof, PC; van der Valk, PG; van Hees, C; van Neer, P, 2006) |
| "We tried to clarify whether the treatment of plaque psoriasis as an inpatient with dithranol and narrow band UV-B 311 nm is still appropriate and economical when compared to biologics such as efalizumab." | 2.71 | [Health economic aspects of psoriasis therapy. Is inpatient topical treatment of plaque-type psoriasis in this age of biologics still appropriate from both medical and economic viewpoints?]. ( Hahn, M; Schulz, T, 2005) |
| "Psoriasis is a chronic skin disease with substantial impact on patients' social and relational ways of living and subsequently on their quality of life." | 2.71 | The effect of treatment on quality of life in psoriasis patients. ( de Boo, T; Krabbe, PF; Prins, M; Swinkels, QO; van de Kerkhof, PC; van der Valk, PG, 2005) |
| "We also estimated the area involved in recurrence of the lesion as a percentage of the baseline area." | 2.70 | Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. ( de Boo, T; Gerritsen, MJ; Kucharekova, M; Prins, M; Swinkels, OQ; van de Kerkhof, PC; van der Valk, PG, 2002) |
| "At the end of treatment, the psoriasis area and severity index had decreased by 57." | 2.70 | Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis. ( Green, C; Hamberg, KJ; Hutchinson, PE; Jensen, JK; Kidson, P; Kragballe, K; Larsen, FG; Munro, CS; Tillman, DM; Van de Kerkhof, PC, 2002) |
| "Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0." | 2.69 | A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998) |
| " We used low-dose narrow-band UVB phototherapy, combined with balneotherapy, short-contact anthralin, liquor carbonis detergens and calcipotriol for treatment of psoriatic patients in our day care centre." | 2.69 | Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation. ( Bos, JD; de Rie, MA; Out, TA, 1998) |
| " The efficacy of whole body exposure to narrow-band UVB (311 nm) combined with dithranol in psoriasis has not been evaluated to date." | 2.69 | Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study. ( Böni, R; Burg, G; Carrozza, P; Häusermann, P; Nestle, FO, 2000) |
| " Safety was determined from reports of adverse events and blood chemistry analysis." | 2.69 | The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. ( Hutchinson, PE; Marks, R; White, J, 2000) |
| "The efficacy of home treatment of psoriasis with a new dithranol formulation, Micanol, was investigated in three studies." | 2.67 | Short-contact treatment at home with Micanol. ( Agren, S; Arlés, UB; Björnberg, A; Brolund, L; Pedersen, NB; Tegner, E; Volden, G, 1992) |
| "The present findings reveal that a pretreatment of psoriasis with topical glucocorticoids reduces the response to dithranol and the duration of remission." | 2.67 | [The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis]. ( Mahrle, G; Schulze, HJ, 1990) |
| "Butantrone has an antipsoriatic activity almost equal to that of dithranol." | 2.66 | Comparison of dithranol and butantrone in short contact therapy of psoriasis. ( Göransson, A, 1987) |
| "Psoriasis is difficult to manage in general practice, mainly because the standard treatments produce side effects, or are ineffective in both the short and long term." | 2.66 | Low concentration dithranol and coal tar (Psorin) in psoriasis: a comparison with alcoholic coal tar extract and allantoin (Alphosyl). ( Harrington, CI, 1989) |
| "5% is an alternative in the treatment of psoriasis vulgaris on the face region as shown by bilateral comparison studies with fluocinolone acetonide 0." | 2.66 | [Low-dose dithranol in psoriasis of the face]. ( Heller, G, 1989) |
| "Psoriasis is one of the most common chronic skin diseases, affecting 1%-3% of the general population." | 2.58 | Use of topical therapies for pediatric psoriasis: A systematic review. ( Gholam, K; Kravvas, G, 2018) |
| "Topical treatments for psoriasis include corticosteroids, vitamin D derivatives, tazarotene, anthralin, tacrolimus, pimecrolimus, and newer formulations of tar." | 2.53 | Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence. ( Stein Gold, LF, 2016) |
| "Topical therapies are the mainstream treatment of psoriasis because most patients have mild disease." | 2.52 | An update on topical therapies for mild-moderate psoriasis. ( van de Kerkhof, PC, 2015) |
| "The only agent licensed for the treatment of psoriasis in patients above the age of 8 years is etanercept if classical treatment has failed." | 2.48 | [Children and adolescents with psoriasis. What therapy is recommended?]. ( Sticherling, M, 2012) |
| "Psoriasis is a chronic inflammatory disease causing important physical and psychological morbidity." | 2.45 | [Topical treatments for psoriasis in 2009]. ( Laffitte, E; Thielen, AM, 2009) |
| "Psoriasis is a chronic skin disease that affects millions of people throughout the world." | 2.44 | Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. ( Jiaravuthisan, MM; Muhn, CY; Murphy, F; Sasseville, D; Vender, RB, 2007) |
| "Advances in topical treatments for psoriasis have kept pace with a rapidly evolving comprehension of its pathogenesis, making a review of current therapies useful for those who treat psoriasis." | 2.43 | Topical therapies for psoriasis: evidence-based review. ( Afifi, T; de Gannes, G; Huang, C; Zhou, Y, 2005) |
| "Psoriasis is a common disease in children and adolescents." | 2.43 | Treatment of childhood psoriasis. ( Ceović, R; Husar, K; Kostović, K; Lipozencić, J; Murat-Susić, S; Pasić, A; Skerlev, M, 2006) |
| "Psoriasis is a frequent, chronic, clinically variable inflammatory disease of unknown etiology, affecting primarily the skin and the joints." | 2.43 | [The immunology of psoriasis: from basic research to the bedside]. ( Gyulai, R; Kemény, L, 2006) |
| " Our purpose is to compare the rates of adverse events associated with different topical psoriasis treatments." | 2.42 | A systematic review of adverse effects associated with topical treatments for psoriasis. ( Bruner, CR; Feldman, SR; Fleischer, AB; Ventrapragada, M, 2003) |
| "Psoriasis is a complex disorder that negatively impacts quality of life." | 2.41 | Advances in psoriasis treatment. ( Feldman, S, 2000) |
| "Salicylic acid 5 to 10% has a pronounced keratolytic effect." | 2.41 | Psoriasis of the scalp. Diagnosis and management. ( Franssen, ME; van de Kerkhof, PC, 2001) |
| "Psoriasis affects more than 6% of Australian adults." | 2.41 | Management of psoriasis. ( Cowen, P, 2001) |
| "Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population." | 2.40 | Topical psoriasis therapy. ( Federman, DG; Froelich, CW; Kirsner, RS, 1999) |
| "Treatment of psoriasis is rapidly changing with improved understanding of the pathogenesis of the disease." | 2.39 | Therapeutic progress. II: Treatment of psoriasis. ( Lewis, HM, 1994) |
| "Dithranol is highly effective in the treatment of psoriasis." | 2.38 | Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. ( Braun-Falco, O; Kemény, L; Ruzicka, T, 1990) |
| "Psoriasis is a disease where changes in epidermal proliferation may be an important factor." | 2.37 | Animal assays for anti-psoriatic, retinoid and sun protective agents. ( Ashton, R; Connor, MJ; Lowe, NJ; Wortzman, M, 1984) |
| "Anthralin was first synthesized in 1916." | 2.36 | Anthralin: historical and current perspectives. ( Andre, P; Ashton, RE; Lowe, NJ; Whitefield, M, 1983) |
| "The disease of psoriasis is examined as to its incidence, etiology, clinical manifestations, and possible complications." | 2.36 | Treatment of psoriasis. ( Bryant, BG, 1980) |
| "Psoriasis is a disease of major importance, the cause of which is unknown and treatment often difficult." | 2.36 | Psoriasis: current advances in etiology and treatment. ( Cram, DL, 1981) |
| "Psoriasis is a chronic, relapsing dermatosis characterised by scaling, erythema, and less commonly pustulation." | 2.36 | Psoriasis: current concepts in management. ( Comaish, JS; Hodge, L, 1977) |
| "Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence." | 1.56 | Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. ( Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ, 2020) |
| "Psoriasis is a chronic inflammatory disease that affects 1." | 1.51 | Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. ( Arnone, M; Azulay-Abulafia, L; Bernardo, WM; Bortoletto, MCC; Bressan, AL; Carvalho, AVE; Felix, PAO; Fieri, LC; Jaime, TJ; Magalhaes, RF; Neffá, JM; Nunes, DH; Oliveira, MFSP; Ramos, AMC; Romiti, R; Souza, CDS; Takahashi, MDF; Terena, AC, 2019) |
| "Psoriasis is associated with metabolic syndrome and cardiovascular disease." | 1.46 | Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis. ( Bacharewicz-Szczerbicka, J; Baran, A; Flisiak, I; Myśliwiec, H; Świderska, M, 2017) |
| "Psoriasis is a common, immune-mediated inflammatory skin disease characterized by red, heavily scaled plaques." | 1.42 | Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells. ( Broadhurst, D; Dunn, WB; Goodacre, R; Griffiths, CE; Hollywood, KA; Winder, CL; Xu, Y, 2015) |
| " Safety was assessed by recording adverse events." | 1.40 | The effectiveness and safety of short-contact dithranol therapy in paediatric psoriasis: a prospective comparison of regular day care and day care with telemedicine. ( Beulens, CA; de Jong, EM; Oostveen, AM; Seyger, MM; van de Kerkhof, PC, 2014) |
| "Psoriasis is a heterogeneous inflammatory disorder that targets the skin and joints." | 1.39 | Improving outcomes in patients with psoriasis. ( Tidman, MJ, 2013) |
| " These studies demonstrate that PPI can be exploited to improve the topical bioavailability of the molecules in a controlled pattern." | 1.39 | Hyperbranched dendritic nano-carriers for topical delivery of dithranol. ( Agrawal, U; Gupta, U; Jain, NK; Mehra, NK, 2013) |
| "Established treatments for psoriasis are generally based on antiproliferative, anti-inflammatory, or differentiation-modifying activity, or a combination of these effects." | 1.36 | Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assay. ( Anderson, RJ; Cunningham, A; Donaldson, M; George, SE; Groundwater, PW, 2010) |
| "Linear psoriasis is a very unusual clinical variation of psoriasis." | 1.35 | Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions. ( Bröcker, EB; Garbaraviciene, J; Hamm, H; Seitz, CS, 2009) |
| "(1) Plaque psoriasis is the most common form of psoriasis in children." | 1.35 | Childhood psoriasis: often favorable outcome. ( , 2009) |
| "Psoriasis is characterized by excessive proliferation of keratinocytes accompanying acanthosis and incomplete differentiation." | 1.34 | Altered expression of prohibitin in psoriatic lesions and its cellular implication. ( Hwang, HY; Kim, SY; Kim, TY; Kim, Y, 2007) |
| "Anthralin is a potent topical drug, inducing clearance of psoriatic plaques." | 1.33 | The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria. ( Birch-Machin, MA; Emmett, N; Frank, A; McGill, A; Reynolds, NJ; Turnbull, DM, 2005) |
| "Dithranol has been used to treat psoriasis for decades." | 1.33 | Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin. ( Dobo, E; Gulya, K; Orojan, I; Szigeti, C; Varszegi, S, 2006) |
| "Stubborn and extensive dermatoses, such as psoriasis vulgaris or atopic dermatitis (eczema), are indications for phototherapeutic methods." | 1.32 | [Phototherapy and photochemotherapy of inflammatory dermatoses]. ( Kerscher, M; Peter, RU; Pillekamp, H; Schiener, R, 2003) |
| "Psoriasis is regarded as a Th1-cell type disease." | 1.32 | Interleukin 4 plasma levels in psoriasis vulgaris patients. ( Dziankowska-Bartkowiak, B; Sysa-Jedrzejowska, A; Wyczółkowska, J; Zalewska, A, 2004) |
| "Danthrone was inactive." | 1.29 | Down-regulation of epidermal growth factor receptors by dithranol. ( Arenberger, P; Kemény, L; Michel, G; Ruzicka, T, 1993) |
| "Our findings suggest that dithranol treatment of a psoriasis plaque is associated with a decrease in oxygen radical generating capacity in vivo." | 1.29 | Effects of dithranol on neutrophil superoxide generation in patients with psoriasis. ( Burton, JL; Donnell, VO; Kavanagh, GM, 1996) |
| "Although many other topical treatments for psoriasis (occlusive therapy and vitamin D3 analogues) result in a prominent reduction in the amount of transglutaminase and involucrin positive cell layers, the effect of dithranol on these markers is minimal." | 1.29 | Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream. ( de Jong, EM; van de Kerkhof, PC; van der Vleuten, CJ, 1996) |
| "Anthralin was found to inhibit the enzyme activity in a dose-dependent manner but not to display any stimulatory effects." | 1.28 | The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of action. ( Fruchtmann, R; Hegemann, L; Mahrle, G; Müller-Peddinghaus, R; van Rooijen, LA, 1992) |
| "Recently the treatment of psoriasis with vitamin D3, its metabolites or analogues, has been reported to be clinically effective and free from side effects." | 1.28 | Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis. ( Cunliffe, WJ; Holland, DB; Roberts, SG; West, MR; Wood, EJ, 1989) |
| "5-1% dithranol in white petrolatum were used in combination with UVB." | 1.28 | Ditrastick combined with UVB. An alternative regimen for plaque psoriasis. ( Brandt, H, 1989) |
| "Anthralin ("minute treatment"), tar, corticosteroids, photochemotherapy and retinoids are the most frequently used treatments, some by the general practitioner, other by the dermatologist." | 1.28 | [Ambulatory treatment of psoriasis]. ( Tapernoux, B, 1989) |
| " Within a few days the dosage was increased to 3% dithranol and the application time to 20 min if possible." | 1.27 | [Experiences with high-dosage short-term dithranol therapy of psoriasis]. ( Göring, HD; Voss, M, 1984) |
| "Because psoriasis is a disease of unknown etiology, all treatments are based on empirical experience and diverse scientific theories." | 1.27 | Recent advances in the treatment of psoriasis. ( Abel, EA; Charuworn, A; Farber, EM, 1983) |
| "Patients with untreated, active psoriasis had increased chemotactic response of their monocytes and neutrophils to N-formyl-methionyl-leucyl-phenylalanine." | 1.27 | The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin. ( Ternowitz, T, 1987) |
| "8 of these 13 reacted with blister formation after exposure to 0." | 1.27 | Irritant potential of dithranol. ( Haustein, UF; Lohrisch, I, 1986) |
| "A method of treating psoriasis without the use of corticosteroids or antimitotic agents is described." | 1.24 | Ingram method of treating psoriasis. ( Comaish, S, 1965) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 329 (58.65) | 18.7374 |
| 1990's | 118 (21.03) | 18.2507 |
| 2000's | 72 (12.83) | 29.6817 |
| 2010's | 38 (6.77) | 24.3611 |
| 2020's | 4 (0.71) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, K | 16 |
| Leukel, P | 1 |
| Ziereis, K | 2 |
| Gawlik, I | 2 |
| Prinz, H | 5 |
| Huang, HS | 2 |
| Breu, K | 3 |
| Sellmer, A | 1 |
| Wiegrebe, W | 6 |
| Reindl, H | 2 |
| Putic, A | 2 |
| Stecher, L | 2 |
| Reichstein, A | 1 |
| Vortherms, S | 1 |
| Bannwitz, S | 1 |
| Tentrop, J | 1 |
| Petch, D | 1 |
| Anderson, RJ | 3 |
| Cunningham, A | 2 |
| George, SE | 3 |
| Hibbs, DE | 1 |
| Liu, R | 1 |
| Mackay, SP | 1 |
| Paul, A | 1 |
| Small, DA | 1 |
| Groundwater, PW | 3 |
| Kussini, J | 1 |
| Charalambous, A | 1 |
| Sachsenweger, F | 1 |
| Steinert, M | 1 |
| Chat, VS | 1 |
| Kearns, DG | 1 |
| Uppal, SK | 1 |
| Han, G | 1 |
| Wu, JJ | 2 |
| Menter, A | 3 |
| Cordoro, KM | 1 |
| Davis, DMR | 1 |
| Kroshinsky, D | 1 |
| Paller, AS | 1 |
| Armstrong, AW | 1 |
| Connor, C | 1 |
| Elewski, BE | 1 |
| Gelfand, JM | 1 |
| Gordon, KB | 1 |
| Gottlieb, AB | 3 |
| Kaplan, DH | 1 |
| Kavanaugh, A | 1 |
| Kiselica, M | 1 |
| Kivelevitch, D | 1 |
| Korman, NJ | 1 |
| Lebwohl, M | 5 |
| Leonardi, CL | 1 |
| Lichten, J | 1 |
| Lim, HW | 1 |
| Mehta, NN | 1 |
| Parra, SL | 1 |
| Pathy, AL | 1 |
| Farley Prater, EA | 1 |
| Rupani, RN | 1 |
| Siegel, M | 1 |
| Stoff, B | 1 |
| Strober, BE | 1 |
| Wong, EB | 1 |
| Hariharan, V | 1 |
| Elmets, CA | 1 |
| Kadian, V | 1 |
| Kumar, S | 1 |
| Saini, K | 1 |
| Kakkar, V | 1 |
| Rao, R | 1 |
| Melhorn, S | 1 |
| Holstein, J | 1 |
| Fehrenbacher, B | 1 |
| Brück, J | 1 |
| Müller-Hermelink, E | 1 |
| Schäfer, I | 1 |
| Carevic, M | 1 |
| Schittek, B | 1 |
| Schaller, M | 1 |
| Ghoreschi, K | 1 |
| Eberle, FC | 1 |
| Kravvas, G | 1 |
| Gholam, K | 1 |
| Sathe, P | 1 |
| Saka, R | 1 |
| Kommineni, N | 1 |
| Raza, K | 2 |
| Khan, W | 1 |
| Arnone, M | 1 |
| Takahashi, MDF | 1 |
| Carvalho, AVE | 1 |
| Bernardo, WM | 1 |
| Bressan, AL | 1 |
| Ramos, AMC | 1 |
| Terena, AC | 1 |
| Souza, CDS | 1 |
| Nunes, DH | 1 |
| Bortoletto, MCC | 1 |
| Oliveira, MFSP | 1 |
| Neffá, JM | 1 |
| Fieri, LC | 1 |
| Azulay-Abulafia, L | 1 |
| Felix, PAO | 1 |
| Magalhaes, RF | 1 |
| Romiti, R | 1 |
| Jaime, TJ | 1 |
| Tidman, MJ | 1 |
| Haswell, M | 1 |
| Agrawal, U | 1 |
| Mehra, NK | 1 |
| Gupta, U | 1 |
| Jain, NK | 1 |
| Oostveen, AM | 2 |
| Beulens, CA | 1 |
| van de Kerkhof, PC | 25 |
| de Jong, EM | 7 |
| Seyger, MM | 4 |
| Anstey, A | 1 |
| van Geel, MJ | 1 |
| Hoppenreijs, EP | 1 |
| Hendriks, JC | 1 |
| Painsi, C | 2 |
| Patscheider, M | 2 |
| Inzinger, M | 2 |
| Huegel, R | 1 |
| Lange-Asschenfeldt, B | 2 |
| Quehenberger, F | 2 |
| Wolf, P | 2 |
| Feely, MA | 1 |
| Smith, BL | 1 |
| Weinberg, JM | 1 |
| Hollywood, KA | 1 |
| Winder, CL | 1 |
| Dunn, WB | 1 |
| Xu, Y | 1 |
| Broadhurst, D | 1 |
| Griffiths, CE | 3 |
| Goodacre, R | 1 |
| Gniadecki, R | 1 |
| Archid, R | 1 |
| Duerr, HP | 1 |
| Patzelt, A | 1 |
| Philipp, S | 1 |
| Röwert-Huber, HJ | 1 |
| Ulrich, M | 1 |
| Meinke, MC | 1 |
| Knorr, F | 1 |
| Lademann, J | 1 |
| Myśliwiec, H | 4 |
| Myśliwiec, P | 1 |
| Baran, A | 2 |
| Flisiak, I | 3 |
| Stein Gold, LF | 1 |
| Svendsen, MT | 1 |
| Jeyabalan, J | 1 |
| Andersen, KE | 1 |
| Andersen, F | 1 |
| Johannessen, H | 1 |
| Świderska, M | 1 |
| Bacharewicz-Szczerbicka, J | 1 |
| Seitz, CS | 1 |
| Garbaraviciene, J | 1 |
| Bröcker, EB | 2 |
| Hamm, H | 1 |
| Thielen, AM | 1 |
| Laffitte, E | 1 |
| Wollina, U | 5 |
| Schmidt, WD | 3 |
| Koch, A | 3 |
| Scheibe, A | 3 |
| Erfurth, F | 1 |
| Fassler, D | 1 |
| de Jager, ME | 2 |
| Donaldson, M | 1 |
| Seme, B | 2 |
| Streit, I | 2 |
| Sticherling, M | 2 |
| Augustin, M | 2 |
| Boehncke, WH | 2 |
| Christophers, E | 2 |
| Domm, S | 1 |
| Gollnick, H | 1 |
| Reich, K | 1 |
| Mrowietz, U | 2 |
| Strohal, R | 1 |
| Puig, L | 1 |
| Chouela, E | 1 |
| Tsai, TF | 1 |
| Melin, J | 1 |
| Freundlich, B | 1 |
| Molta, CT | 1 |
| Fuiman, J | 1 |
| Pedersen, R | 1 |
| Robertson, D | 1 |
| Malisiewicz, B | 1 |
| Murer, C | 1 |
| Pachlopnik Schmid, J | 1 |
| French, LE | 1 |
| Schmid-Grendelmeier, P | 1 |
| Navarini, AA | 1 |
| Rogalski, C | 1 |
| Grunewald, S | 1 |
| Schetschorke, M | 1 |
| Bodendorf, MO | 1 |
| Kauer, F | 1 |
| Simon, JC | 1 |
| Paasch, U | 1 |
| Ronpirin, C | 1 |
| Tencomnao, T | 1 |
| Katare, OP | 3 |
| Setia, A | 1 |
| Bhatia, A | 1 |
| Singh, B | 1 |
| Schopf, RE | 1 |
| Langendorf, Y | 1 |
| Benz, RE | 1 |
| Färber, L | 2 |
| Benes, P | 1 |
| Hartman, M | 1 |
| Prins, M | 5 |
| Swinkels, OQ | 5 |
| Severens, JL | 1 |
| De Boo, T | 3 |
| Van Der Wilt, GJ | 1 |
| Van Der Valk, PG | 8 |
| Agarwal, R | 2 |
| Saraswat, A | 2 |
| Kaur, I | 3 |
| Kumar, B | 2 |
| Naldi, L | 6 |
| Rzany, B | 5 |
| Kirkup, ME | 1 |
| Sabroe, RA | 1 |
| Kavanagh, GM | 2 |
| Downs, AM | 1 |
| Sansom, JE | 1 |
| de Berker, DA | 1 |
| Dunnill, MG | 1 |
| Kennedy, CT | 1 |
| Archer, CB | 1 |
| Bruner, CR | 1 |
| Feldman, SR | 1 |
| Ventrapragada, M | 1 |
| Fleischer, AB | 1 |
| Schiener, R | 1 |
| Pillekamp, H | 1 |
| Kerscher, M | 1 |
| Peter, RU | 1 |
| Bendkowski, W | 1 |
| Hadas, E | 1 |
| Swietochowska, E | 1 |
| Wielkoszyński, T | 1 |
| Ostrowska, Z | 1 |
| Szapska, B | 1 |
| Hofmann, UB | 1 |
| Eggert, AA | 1 |
| Goebeler, M | 1 |
| Margolin, L | 1 |
| Haliulin, Y | 1 |
| PENEV, S | 1 |
| ATANASOV, L | 1 |
| WEBER, G | 1 |
| ROSS, JB | 2 |
| MCELLIGOTT, TF | 1 |
| ROUT, M | 1 |
| Serwin, AB | 1 |
| Hukalowicz, K | 1 |
| Porebski, P | 1 |
| Borawska, M | 1 |
| Chodynicka, B | 2 |
| McBride, SR | 1 |
| Walker, P | 1 |
| Reynolds, NJ | 3 |
| Peus, D | 2 |
| Beyerle, A | 2 |
| Vasa, M | 1 |
| Pott, M | 2 |
| Meves, A | 2 |
| Pittelkow, MR | 3 |
| Tang, L | 1 |
| Cao, L | 1 |
| Sundberg, JP | 1 |
| Lui, H | 2 |
| Shapiro, J | 1 |
| Zalewska, A | 1 |
| Wyczółkowska, J | 1 |
| Dziankowska-Bartkowiak, B | 1 |
| Sysa-Jedrzejowska, A | 2 |
| Ghorpade, A | 1 |
| Kucharekova, M | 3 |
| Lieffers, L | 1 |
| McGill, A | 1 |
| Frank, A | 1 |
| Emmett, N | 1 |
| Turnbull, DM | 1 |
| Birch-Machin, MA | 1 |
| Hahn, M | 1 |
| Schulz, T | 1 |
| Afifi, T | 1 |
| de Gannes, G | 1 |
| Huang, C | 1 |
| Zhou, Y | 1 |
| Lee, E | 1 |
| Koo, J | 2 |
| Krabbe, PF | 1 |
| Swinkels, QO | 1 |
| Ummenhofer, B | 2 |
| Haas, N | 1 |
| Wulff-Woesten, A | 1 |
| Sterry, W | 3 |
| Meffert, H | 5 |
| Eisenmann, A | 1 |
| Wohlrab, J | 1 |
| Gerdes, S | 1 |
| de Rie, MA | 3 |
| de Vries, HJ | 1 |
| Damstra, R | 1 |
| Oranje, AP | 2 |
| de Waard-van der Spek, FB | 2 |
| van Neer, P | 1 |
| Lijnen, RL | 2 |
| Kunkeler, AC | 2 |
| van Hees, C | 1 |
| Haertlein, NG | 1 |
| Hol, CW | 2 |
| Orojan, I | 1 |
| Szigeti, C | 1 |
| Varszegi, S | 1 |
| Dobo, E | 1 |
| Gulya, K | 1 |
| Wozniacka, A | 1 |
| Szajerski, P | 1 |
| Adamus, J | 1 |
| Gebicki, J | 1 |
| Ceović, R | 1 |
| Pasić, A | 1 |
| Lipozencić, J | 1 |
| Murat-Susić, S | 1 |
| Skerlev, M | 1 |
| Husar, K | 1 |
| Kostović, K | 1 |
| Gyulai, R | 1 |
| Kemény, L | 7 |
| Jiaravuthisan, MM | 1 |
| Sasseville, D | 1 |
| Vender, RB | 1 |
| Murphy, F | 1 |
| Muhn, CY | 1 |
| Kim, SY | 1 |
| Kim, Y | 1 |
| Hwang, HY | 1 |
| Kim, TY | 1 |
| Stiefelhagen, P | 1 |
| de Korte, J | 1 |
| Sprangers, MA | 1 |
| Damstra, RJ | 1 |
| Mustakallio, KK | 9 |
| McMinn, RM | 1 |
| Woods, MS | 1 |
| Fry, L | 2 |
| Rogers, S | 9 |
| Marks, J | 8 |
| Shuster, S | 17 |
| Pullmann, H | 3 |
| Enderer, K | 1 |
| Steigleder, GK | 10 |
| Portnoy, B | 1 |
| Beck, MH | 3 |
| Chalmers, RJ | 1 |
| Marks, JM | 3 |
| Larkö, O | 2 |
| Swanbeck, G | 2 |
| Kolari, PJ | 2 |
| Brandt, H | 4 |
| Göransson, AM | 1 |
| Brun, P | 2 |
| Juhlin, L | 7 |
| Schalla, W | 2 |
| Lawrence, CM | 8 |
| Howel, D | 1 |
| Saihan, EM | 1 |
| Albano, J | 1 |
| Burton, JL | 3 |
| Ashton, RE | 2 |
| Andre, P | 1 |
| Lowe, NJ | 9 |
| Whitefield, M | 8 |
| Guerrier, CJ | 1 |
| Porter, DI | 1 |
| Fredriksson, T | 1 |
| Connor, MJ | 1 |
| Ashton, R | 1 |
| Wortzman, M | 1 |
| Farber, EM | 9 |
| Nall, L | 2 |
| Donaldson, J | 1 |
| Cunliffe, WJ | 5 |
| Seville, RH | 6 |
| Sircar, JC | 1 |
| Schwender, CF | 1 |
| Bedord, CJ | 1 |
| Young, JM | 1 |
| Wagner, BM | 1 |
| Corbett, M | 1 |
| Coburn, P | 1 |
| Parker, S | 1 |
| Kersey, P | 1 |
| Chapman, P | 1 |
| Rawlins, M | 1 |
| Lawlor, F | 2 |
| Hindson, C | 2 |
| Reshad, H | 1 |
| Barth, JH | 1 |
| Darley, CR | 1 |
| Baker, H | 2 |
| Martinmaa, J | 1 |
| Vilvala, R | 1 |
| Halmekoski, J | 2 |
| Statham, BN | 4 |
| Ryatt, KS | 4 |
| Rowell, NR | 5 |
| Menter, MA | 1 |
| Whiting, DA | 1 |
| McWilliams, J | 1 |
| Neill, SM | 1 |
| Bugrein, A | 1 |
| Coulson, IH | 1 |
| Greaves, MW | 10 |
| Momtaz-T, K | 1 |
| Parrish, JA | 2 |
| Davies, A | 1 |
| Lubach, D | 2 |
| Maurice, PD | 1 |
| Wätzig, V | 1 |
| Gloor, M | 1 |
| Graf, R | 1 |
| Wirth, H | 1 |
| Landau, M | 1 |
| Puschmann, M | 1 |
| Hindryckx, P | 1 |
| De Bersaques, J | 2 |
| Koudsi, H | 1 |
| Verschoore, M | 1 |
| Schaefer, H | 4 |
| Roberts, DL | 1 |
| Ellis, JP | 1 |
| Hindson, TC | 1 |
| Hudson, PM | 1 |
| Rhodes, EL | 1 |
| Vollum, DI | 1 |
| Walker, AE | 1 |
| Gonçalo, S | 1 |
| Sousa, I | 1 |
| Moreno, A | 1 |
| Göring, HD | 1 |
| Voss, M | 1 |
| Schulze, HJ | 10 |
| Bloedhorn, H | 1 |
| Pearlman, DL | 1 |
| Burns, J | 1 |
| Cannon, TC | 1 |
| Engelhard, CS | 1 |
| Marosi, I | 1 |
| Balogh, G | 1 |
| Cseplák, G | 1 |
| Finnen, MJ | 1 |
| Mahrle, G | 14 |
| Marghescu, S | 1 |
| Rudolph, PO | 1 |
| Ferguson, A | 1 |
| Maden, CJ | 1 |
| Peachey, RD | 1 |
| Champion, RH | 1 |
| Vella Briffa, D | 3 |
| Warin, AP | 3 |
| Grosshans, E | 5 |
| Henry, M | 2 |
| Tell, G | 2 |
| Schechter, PJ | 2 |
| Böhlen, P | 2 |
| Grove, J | 3 |
| Koch-Weser, J | 3 |
| Juillard, J | 1 |
| Kingston, T | 1 |
| Marks, R | 3 |
| Biella, U | 2 |
| Heller, G | 4 |
| Barth, J | 4 |
| Gisslèn, H | 1 |
| Nordin, P | 1 |
| Abel, EA | 3 |
| Charuworn, A | 1 |
| Diffey, B | 1 |
| Downey, A | 1 |
| Runne, U | 4 |
| Kunze, J | 4 |
| Elbracht, C | 1 |
| Landes, E | 2 |
| Nyfors, A | 1 |
| Dimitrova, I | 1 |
| Kostova, M | 1 |
| Mitrova, Z | 1 |
| Thirumoorthy, T | 2 |
| Rajan, VS | 1 |
| Schauder, S | 5 |
| Morhenn, VB | 1 |
| Orenberg, EK | 3 |
| Kaplan, J | 1 |
| Pfendt, E | 1 |
| Terrell, C | 1 |
| Engleman, EG | 1 |
| Marsden, JR | 1 |
| Coburn, PR | 1 |
| Williamson, DM | 2 |
| Rothe, LL | 1 |
| Bryant, BG | 1 |
| Wilson, PD | 1 |
| Ive, FA | 1 |
| Cram, DL | 1 |
| Khan, SA | 1 |
| Gatecliff, M | 1 |
| Tosh, J | 1 |
| McDonald, CJ | 1 |
| Budden, MG | 1 |
| Ehmann, CW | 2 |
| Voorhees, JJ | 3 |
| Anderson, TF | 1 |
| Young, MM | 1 |
| Guptill, J | 1 |
| Jillson, OF | 1 |
| Mali, JW | 2 |
| Steger, JW | 1 |
| Hollander, A | 1 |
| Morrow, NE | 1 |
| Anderson, PC | 1 |
| Marley, WM | 1 |
| Hernandez, AD | 1 |
| Josephs, JA | 1 |
| Dawkins, L | 1 |
| Westphal, HJ | 1 |
| Schütt, C | 1 |
| Hartwich, M | 1 |
| Roost, U | 1 |
| Göcke, H | 1 |
| Kaben, U | 1 |
| Lauritz, B | 1 |
| Schaltegger, A | 3 |
| Bloch, U | 1 |
| Krebs, A | 7 |
| Wargon, O | 1 |
| Paver, WK | 1 |
| Taube, KM | 3 |
| Zaumseil, RP | 1 |
| Wohlrab, W | 4 |
| Reiss, CJ | 1 |
| de Groot, AC | 1 |
| Nater, JP | 1 |
| Petres, J | 1 |
| Brody, I | 5 |
| Shroot, B | 4 |
| van Scott, EJ | 1 |
| Yu, RJ | 1 |
| Schaltegger, H | 1 |
| Langner, A | 1 |
| Chorzelski, TP | 1 |
| Fraczykowska, M | 1 |
| Beutner, EH | 1 |
| Jablonska, S | 1 |
| Briffa, DV | 2 |
| Raab, WP | 1 |
| Misch, K | 1 |
| Davies, M | 1 |
| Greaves, M | 2 |
| Coutts, A | 1 |
| Chadkirk, B | 1 |
| Ernst, TM | 1 |
| Moss, C | 1 |
| Friedmann, PS | 3 |
| Breeding, J | 1 |
| Metz, D | 2 |
| Derbes, VJ | 1 |
| Goldberg, L | 1 |
| Köstler, E | 2 |
| Seebacher, C | 2 |
| Wallace, B | 1 |
| Watts, P | 1 |
| Stables, GS | 1 |
| Akhurst, RJ | 1 |
| Mackie, RM | 2 |
| Lewis, HM | 1 |
| Kowalzick, L | 3 |
| Neuber, K | 2 |
| Weichenthal, M | 1 |
| Köhler, I | 2 |
| Ring, J | 2 |
| Ockenfels, HM | 1 |
| Nussbaum, G | 1 |
| Schultewolter, T | 1 |
| Burger, PM | 1 |
| Goos, M | 2 |
| Gottlieb, SL | 1 |
| Heftler, NS | 1 |
| Gilleaudeau, P | 1 |
| Johnson, R | 1 |
| Vallat, VP | 1 |
| Wolfe, J | 1 |
| Krueger, JG | 2 |
| Healy, E | 1 |
| Smith, MD | 1 |
| Harrison, D | 1 |
| Doherty, E | 1 |
| Campbell, C | 1 |
| Rees, JL | 1 |
| Levell, NJ | 1 |
| Munro, CS | 2 |
| Burden, AD | 2 |
| Muston, H | 1 |
| Zvulunov, A | 1 |
| Anisfeld, A | 1 |
| Metzker, A | 1 |
| Weidinger, G | 1 |
| Kaufmann, R | 1 |
| Goodfield, MJ | 2 |
| Hull, SM | 1 |
| Simpson, KR | 1 |
| Michel, G | 3 |
| Dobozy, A | 3 |
| Ruzicka, T | 7 |
| Auer, T | 1 |
| Bacharach-Buhles, M | 2 |
| el-Gammal, S | 1 |
| Stücker, M | 3 |
| Panz, B | 1 |
| Popp, C | 1 |
| Hoffmann, K | 3 |
| Happe, M | 2 |
| Altmeyer, P | 4 |
| Bonnekoh, B | 1 |
| Wevers, A | 1 |
| Hegemann, L | 2 |
| Kenderessy, AS | 1 |
| Olasz, E | 1 |
| Farkas, B | 1 |
| Arenberger, P | 3 |
| Bildau, H | 1 |
| Berth-Jones, J | 2 |
| Phillips, DH | 1 |
| Alldrick, AJ | 1 |
| Storbeck, K | 1 |
| Hölzle, E | 2 |
| Schürer, N | 1 |
| Lehmann, P | 1 |
| Plewig, G | 1 |
| Kragballe, K | 2 |
| Young, DW | 1 |
| Downey, DJ | 2 |
| Abel, E | 1 |
| Zanolli, M | 1 |
| Drake, L | 1 |
| Schmidt, KN | 1 |
| Podda, M | 1 |
| Packer, L | 3 |
| Baeuerle, PA | 1 |
| Donnell, VO | 1 |
| Silverman, A | 1 |
| Hairston, JL | 1 |
| Röchling, A | 1 |
| el Gammal, S | 1 |
| Van der Vleuten, CJ | 2 |
| Gerritsen, MJ | 4 |
| Elbers, M | 1 |
| De Jongh, GJ | 1 |
| Dutz, JP | 1 |
| Chodorowska, G | 2 |
| Youn, JI | 1 |
| Kim, BK | 1 |
| Suh, DH | 1 |
| Sander, P | 2 |
| Hermes, N | 2 |
| Yamamoto, T | 2 |
| Katayama, I | 2 |
| Nishioka, K | 3 |
| Krbavcic, A | 1 |
| Pecar, S | 1 |
| Schara, M | 1 |
| Out, TA | 1 |
| Bos, JD | 1 |
| Brockmeyer, NH | 1 |
| Frühauf, S | 1 |
| Mertins, L | 1 |
| Barthel, B | 1 |
| Harris, DR | 1 |
| Savolainen, L | 1 |
| Kontinen, J | 1 |
| Alatalo, E | 1 |
| Röning, J | 1 |
| Oikarinen, A | 1 |
| Wall, AR | 1 |
| Poyner, TF | 2 |
| Menday, AP | 2 |
| Federman, DG | 1 |
| Froelich, CW | 1 |
| Kirsner, RS | 1 |
| Burgers, SA | 1 |
| van Vloten, WA | 1 |
| Pietrzak, A | 2 |
| Miturski, R | 1 |
| Krasowska, D | 2 |
| Postawski, K | 1 |
| Lecewicz-Toruń, B | 3 |
| Andrees, U | 1 |
| Grimme, H | 1 |
| Schöpf, E | 1 |
| Simon, J | 1 |
| Asadullah, K | 1 |
| Prösch, S | 1 |
| Audring, H | 1 |
| Büttnerova, I | 1 |
| Volk, HD | 1 |
| Döcke, WD | 1 |
| Mommers, JM | 1 |
| Chadha, V | 1 |
| Shenoi, SD | 1 |
| Parslew, R | 1 |
| Carrozza, P | 1 |
| Häusermann, P | 1 |
| Nestle, FO | 1 |
| Burg, G | 1 |
| Böni, R | 1 |
| Rittner, HL | 1 |
| Weyand, C | 1 |
| Smith, KC | 1 |
| Chu, T | 1 |
| Seneczko, F | 1 |
| Kaszuba, A | 1 |
| Matsuuchi, M | 1 |
| Irimajiri, J | 1 |
| Otoyama, K | 1 |
| Williams, ZV | 1 |
| Hutchinson, PE | 2 |
| White, J | 1 |
| Ashcroft, DM | 1 |
| Li Wan Po, A | 1 |
| Williams, HC | 1 |
| Szepietowski, JC | 1 |
| Bielicka, E | 1 |
| Nockowski, P | 1 |
| Noworolska, A | 1 |
| Wasik, F | 1 |
| Karrer, S | 1 |
| Eholzer, C | 1 |
| Ackermann, G | 1 |
| Landthaler, M | 1 |
| Szeimies, RM | 1 |
| Feldman, S | 1 |
| Lestina, LS | 1 |
| Tosserams, EF | 1 |
| Zachariae, H | 1 |
| Zachariae, R | 1 |
| Blomqvist, K | 1 |
| Davidsson, S | 1 |
| Molin, L | 2 |
| Mørk, C | 1 |
| Sigurgeirsson, B | 1 |
| Messer, G | 1 |
| Rupec, RA | 1 |
| Ali, S | 1 |
| Franssen, ME | 1 |
| Wong, C | 1 |
| Kirby, B | 1 |
| Cowen, P | 1 |
| Comaish, S | 1 |
| Juszkiewicz-Borowiec, M | 1 |
| Czelej, D | 1 |
| Wojnowska, D | 1 |
| Kowal, M | 1 |
| Green, C | 1 |
| Hamberg, KJ | 1 |
| Jensen, JK | 1 |
| Kidson, P | 1 |
| Larsen, FG | 1 |
| Tillman, DM | 1 |
| Montes, LF | 2 |
| Wilborn, WH | 2 |
| Warin, A | 1 |
| Millard, LG | 1 |
| Howell, DR | 1 |
| Beya, MF | 1 |
| Henry, MH | 1 |
| Herrmann, WP | 1 |
| Hammar, H | 3 |
| Waine, E | 1 |
| Hodge, L | 1 |
| Comaish, JS | 1 |
| Johansson, A | 1 |
| Buckley, DB | 1 |
| Koerber, WA | 1 |
| Price, NM | 1 |
| Watson, W | 3 |
| Walker, GB | 2 |
| Proctor, MS | 1 |
| Wilkinson, DI | 1 |
| Cambrai, M | 1 |
| Clar, EJ | 1 |
| Altermatt, C | 1 |
| Müller, G | 1 |
| Sönnichsen, N | 2 |
| Orfanos, CE | 5 |
| Goerz, G | 3 |
| Happle, R | 1 |
| Hofbauer, M | 2 |
| Schimpf, A | 1 |
| Cripps, DJ | 1 |
| Klem, EB | 1 |
| Morison, WL | 2 |
| Fitzpatrick, TB | 1 |
| Herter, A | 1 |
| Lübke, M | 1 |
| Elste, G | 1 |
| Schulze, P | 3 |
| Hardie, RA | 1 |
| Hunter, AA | 1 |
| Debreczeni, M | 1 |
| Balogh, E | 1 |
| Tóth, A | 1 |
| Bober, A | 1 |
| Szczeklik-Franek, A | 1 |
| Wereta-Kubek, M | 1 |
| Christophersen, J | 1 |
| Gammeltoft, M | 1 |
| Dugois, P | 1 |
| Amblard, P | 1 |
| Martel, J | 1 |
| Morin, J | 1 |
| Reymond, JL | 1 |
| Noble, WC | 1 |
| Wolff-Schreiner, EC | 1 |
| Carter, DM | 1 |
| Schwarzacher, HG | 1 |
| Wolff, K | 1 |
| Gerny, H | 1 |
| Storck, H | 1 |
| Zingheim, M | 1 |
| Hirvonen, H | 1 |
| Faber, EM | 1 |
| North, C | 1 |
| Weinstein, GD | 1 |
| Stankler, L | 1 |
| Dave, VK | 1 |
| Raab, W | 2 |
| Kuiper, JP | 1 |
| van de Staak, WJ | 1 |
| Groels, AP | 1 |
| Verbov, J | 2 |
| Wrench, R | 1 |
| Britten, AZ | 1 |
| Marriott, PJ | 1 |
| Munro, DD | 1 |
| Khandke, L | 1 |
| Krane, JF | 1 |
| Staiano-Coico, L | 1 |
| Ashinoff, R | 1 |
| Jekler, J | 1 |
| Di Nardo, A | 1 |
| Seidenari, S | 1 |
| Giannetti, A | 1 |
| Fedi, AM | 2 |
| Lotti, T | 4 |
| Meo, AL | 1 |
| Rizzo, A | 1 |
| Leoncini, P | 1 |
| Murdoch, D | 1 |
| Clissold, SP | 1 |
| Chu, AC | 1 |
| Dodd, WA | 1 |
| Ganpule, M | 1 |
| Griffiths, WA | 1 |
| Haydey, RP | 1 |
| Klaber, MR | 1 |
| Murray, SJ | 1 |
| Jurgensen, HJ | 1 |
| Holder, AJ | 1 |
| Upadrashta, SM | 1 |
| Masajtis, J | 1 |
| Dutkiewicz, J | 1 |
| Członka, R | 1 |
| Broniarczyk-Dyła, G | 1 |
| Arkuszewska, C | 1 |
| Skwarczyńska-Banyś, E | 1 |
| Omulecki, A | 1 |
| Kot, P | 1 |
| Shao, C | 1 |
| Ye, G | 1 |
| Hu, C | 1 |
| Zhang, F | 1 |
| Stapleton, M | 1 |
| Fruchtmann, R | 1 |
| van Rooijen, LA | 1 |
| Müller-Peddinghaus, R | 1 |
| Carrel, CF | 1 |
| Parazzini, F | 1 |
| D'Oro, LC | 1 |
| Cainelli, T | 2 |
| Di Landro, A | 1 |
| Valsecchi, R | 1 |
| Korstanje, MJ | 1 |
| Bosman, B | 1 |
| Matthiesen, T | 1 |
| Hess, V | 1 |
| Friderichs, E | 1 |
| Christensen, OB | 3 |
| Brolund, L | 6 |
| Volden, G | 1 |
| Björnberg, A | 1 |
| Tegner, E | 1 |
| Pedersen, NB | 1 |
| Arlés, UB | 1 |
| Agren, S | 1 |
| Mørk, NJ | 1 |
| Austad, J | 1 |
| Enström, Y | 1 |
| Reidhav, I | 1 |
| Svensson, A | 1 |
| Bjellerup, M | 1 |
| Ridderström, E | 1 |
| Larsson-Stymne, B | 1 |
| Thune, P | 1 |
| Gross, E | 1 |
| van Vlijmen, IM | 1 |
| van Erp, PE | 2 |
| Ramaekers, FC | 1 |
| Troyanovski, SM | 1 |
| de Vet, AA | 1 |
| Pennings, BJ | 1 |
| Ros, JJ | 1 |
| Van der Meer, YG | 1 |
| De Hoop, D | 1 |
| De Kort, WJ | 1 |
| Van Andel, P | 1 |
| Scholz, A | 1 |
| Kadner, H | 1 |
| Tanzer, H | 1 |
| Braun, C | 1 |
| Seidel, M | 1 |
| Kaur, S | 1 |
| Vaishnavi, C | 1 |
| Ganguly, NK | 1 |
| Garg, J | 1 |
| Kohli, M | 1 |
| Sheehan-Dare, RA | 1 |
| Timmerman, MG | 2 |
| Mier, PD | 1 |
| Swinehart, JM | 1 |
| Buchtová, L | 1 |
| Fuchs, J | 3 |
| Nitschmann, WH | 1 |
| Bonan, P | 2 |
| Cannarozzo, G | 1 |
| Panconesi, E | 3 |
| Ramsay, B | 2 |
| Bruce, JM | 3 |
| Berset, JD | 2 |
| Bochner, H | 1 |
| Cohen, E | 1 |
| David, M | 1 |
| Feinstein, A | 1 |
| Freidman-Birnbaum, R | 1 |
| Livshin, R | 1 |
| Melibowski, C | 1 |
| Sandbank, M | 1 |
| Shevach-Millet, M | 1 |
| Tolkin, J | 1 |
| Braun-Falco, O | 2 |
| Viluksela, M | 1 |
| Haasio, K | 1 |
| Männistö, PT | 2 |
| Nitschmann, W | 1 |
| Fiore, M | 1 |
| Bunse, T | 1 |
| Merk, H | 2 |
| Kanerva, L | 1 |
| Gupta, AK | 2 |
| Siegel, MT | 1 |
| Noble, SC | 1 |
| Kirkby, S | 1 |
| Rasmussen, JE | 1 |
| Serfling, U | 1 |
| Rotstein, H | 1 |
| Baker, C | 1 |
| Czernielewski, J | 1 |
| Shroot, S | 1 |
| Göransson, A | 2 |
| Klug, H | 2 |
| Schallreuter, KU | 1 |
| de Mare, S | 2 |
| Calis, N | 2 |
| den Hartog, G | 2 |
| Holland, DB | 2 |
| Wood, EJ | 2 |
| Roberts, SG | 1 |
| West, MR | 1 |
| Turner, DM | 1 |
| Csató, M | 1 |
| Nyirádi, J | 1 |
| Gábor, M | 1 |
| Klinger, R | 1 |
| Wetzker, R | 1 |
| Knopf, B | 4 |
| Barr, RM | 2 |
| Wong, E | 2 |
| Cunningham, FM | 1 |
| Mallet, AI | 1 |
| Remitz, A | 1 |
| Bradley, J | 1 |
| Harrington, CI | 1 |
| Holst, R | 1 |
| Hradil, E | 1 |
| Mashkilleĭson, AL | 1 |
| Golousenko, IIu | 1 |
| Harrison, PV | 1 |
| Smith, JF | 1 |
| Przybilla, B | 3 |
| Kaudewitz, P | 2 |
| Bieber, K | 1 |
| Shakhtmeĭster, IIa | 1 |
| Kaukhova, OIa | 1 |
| Kunin, NA | 1 |
| Shablinskaia, EM | 1 |
| Kozyreva, LG | 1 |
| Higashi, K | 1 |
| Nishiyama, S | 1 |
| Frenk, E | 1 |
| Rohde, BT | 1 |
| DiCicco, LM | 1 |
| Fraki, JE | 2 |
| Tapernoux, B | 1 |
| Baker, BS | 1 |
| Swain, AF | 1 |
| Leonard, JN | 1 |
| Valdimarsson, H | 1 |
| Hanhijärvi, H | 1 |
| Kosma, VM | 1 |
| Collan, Y | 1 |
| Bratzke, B | 1 |
| Albrecht, G | 1 |
| Gruner, S | 1 |
| Strunk, D | 1 |
| Diezel, W | 1 |
| Black, AK | 1 |
| Brain, S | 1 |
| Dickinson, R | 1 |
| Hensby, CN | 1 |
| Tucker, WF | 1 |
| MacNeil, S | 1 |
| Dawson, RA | 1 |
| Tomlinson, S | 1 |
| Bleehen, SS | 1 |
| Paramsothy, Y | 2 |
| Collins, M | 2 |
| Grattan, CE | 2 |
| Christopher, AP | 2 |
| Robinson, M | 2 |
| Cowan, MA | 1 |
| Farr, PM | 2 |
| Diffey, BL | 1 |
| Going, SM | 3 |
| Nimmo, JE | 1 |
| Gawkrodger, DJ | 1 |
| O'Docherty, CS | 1 |
| Percy-Robb, IW | 1 |
| Hunter, JA | 1 |
| Kudejko, J | 1 |
| Chibowska, M | 1 |
| Tyszlukiewicz, D | 1 |
| Kuczyńska, L | 1 |
| Nestorowicz, B | 1 |
| Rogers, MJ | 1 |
| Marks, VJ | 1 |
| Chlebarov, S | 1 |
| Rauh, M | 1 |
| Duhra, P | 1 |
| Rychener, M | 1 |
| Steiger, W | 2 |
| Kalamkarian, AA | 1 |
| Samsonov, VA | 1 |
| Timoshin, GG | 1 |
| Chistiakova, IA | 1 |
| Brown, WR | 1 |
| Rogozinski, TT | 1 |
| Ramsay, CA | 1 |
| Going, S | 1 |
| Young, E | 3 |
| van Weelden, H | 2 |
| Frödin, T | 1 |
| Skogh, M | 1 |
| O'Connell, BM | 1 |
| Dowd, PM | 1 |
| Atkinson, J | 1 |
| Monk, BE | 1 |
| Hehir, ME | 1 |
| Clement, MI | 1 |
| Pembroke, AC | 1 |
| du Vivier, A | 1 |
| Taskinen, J | 1 |
| Haarala, J | 1 |
| Wartiovaara, E | 1 |
| Vardy, D | 1 |
| Werner, E | 1 |
| Dunn, ML | 1 |
| Cockerline, EB | 1 |
| Rice, MR | 1 |
| Römer, J | 1 |
| Wiederanders, B | 1 |
| Wozniak, KD | 2 |
| Fritsch, P | 1 |
| Hönigsmann, H | 1 |
| Finlay, AY | 1 |
| Galosi, A | 2 |
| Schlesier, F | 1 |
| Schaarschmidt, H | 3 |
| Hipler, C | 1 |
| Henkel, U | 1 |
| Roth, H | 1 |
| Bartá, U | 4 |
| Wang, JC | 1 |
| Patel, BG | 1 |
| Lowe, N | 1 |
| Shall, L | 1 |
| Ternowitz, T | 1 |
| Brunner, F | 1 |
| Lidbrink, P | 1 |
| Johannesson, A | 1 |
| Stone, OJ | 1 |
| Lohrisch, I | 2 |
| Haustein, UF | 2 |
| Neumann, JH | 1 |
| Richter, G | 1 |
| Brunetti, L | 1 |
| Reichert, U | 1 |
| Boer, J | 1 |
| Smeenk, G | 1 |
| Wemmer, U | 1 |
| Heid, E | 1 |
| Duschet, P | 1 |
| Schwarz, T | 2 |
| Pusch, M | 1 |
| Wagner, A | 1 |
| Gschnait, F | 2 |
| Kingston, TP | 1 |
| Freeman, K | 1 |
| Ducret, F | 1 |
| Lambelet, P | 1 |
| Löliger, J | 1 |
| Savoy, MC | 1 |
| Schroot, B | 1 |
| Wright, S | 1 |
| Mann, RJ | 1 |
| Jones, SK | 1 |
| Campbell, WC | 1 |
| Agrup, G | 1 |
| Agdell, J | 1 |
| Gordin, A | 1 |
| Sher, MA | 1 |
| Sher, B | 1 |
| Berro, V | 1 |
| MacDonald, KJ | 1 |
| Ellis, CN | 2 |
| Goldfarb, MT | 1 |
| Schmidli, J | 1 |
| Hunziker, T | 1 |
| Sharpe, G | 1 |
| Pflugshaupt, C | 1 |
| Plumier, E | 1 |
| Mayer, KK | 1 |
| Schultz-Amling, W | 1 |
| Rosmarinowski, J | 1 |
| Safar, GJ | 1 |
| Kubka, KD | 1 |
| Newton, JA | 1 |
| Camplejohn, RS | 1 |
| Bowyer, C | 1 |
| Graham, RM | 1 |
| McGibbon, DM | 1 |
| Wright, NA | 1 |
| Gast, W | 1 |
| Drobnitsch, I | 1 |
| Varga, E | 1 |
| Schneider, I | 1 |
| Miller, AC | 1 |
| Suhonen, R | 1 |
| Neittaanmäki, H | 1 |
| Väätäinen, N | 1 |
| Blomfield, I | 1 |
| Sedcole, V | 1 |
| Eilard, U | 1 |
| Edin, L | 1 |
| Gorsulowsky, DC | 1 |
| Fiedler, H | 1 |
| Berman, B | 1 |
| France, DS | 1 |
| Tan, YC | 1 |
| Wong, BY | 1 |
| Watson, A | 1 |
| Wozel, G | 1 |
| Dorn, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis[NCT03348462] | Phase 4 | 20 participants (Actual) | Interventional | 2017-11-30 | Completed | ||
| Spray® and Vectical Ointment® in the Treatment of Plaque Psoriasis[NCT01205880] | Phase 4 | 12 participants (Actual) | Interventional | 2009-12-31 | Completed | ||
| Subclinical Nail Involvement in Relevant Skin Diseases[NCT04092413] | 384 participants (Anticipated) | Observational | 2019-11-01 | Not yet recruiting | |||
| Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic: Nail Disease a Single-blind, Intrapatient Left-to-right Controlled Study.[NCT03263624] | Phase 4 | 30 participants (Anticipated) | Interventional | 2017-10-01 | Not yet recruiting | ||
| A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Study of the Safety and Efficacy of Two Dosing Regimens of QRX-101 (Becocalcidiol) Ointment in the Treatment of Plaque-Type Psoriasis[NCT00373516] | Phase 2 | 150 participants | Interventional | 2004-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
73 reviews available for anthralin and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice.
Topics: Administration, Topical; Anthralin; Calcineurin Inhibitors; Coal Tar; Dermatologic Agents; Emollient | 2022 |
Dithranol: An Insight into its Novel Delivery Cargos for Psoriasis Management.
Topics: Administration, Cutaneous; Animals; Anthralin; Dermatologic Agents; Drug Delivery Systems; Humans; P | 2020 |
Use of topical therapies for pediatric psoriasis: A systematic review.
Topics: Administration, Cutaneous; Adolescent; Anthralin; Calcineurin Inhibitors; Child; Dermatologic Agents | 2018 |
An update on topical therapies for mild-moderate psoriasis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Cholecalcif | 2015 |
Novel psoriasis therapies and patient outcomes, part 1: topical medications.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Biological Factors; Calcineurin Inhibit | 2015 |
Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.
Topics: Administration, Cutaneous; Anthralin; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinati | 2016 |
Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Dermatologic Agents; Drug T | 2017 |
[Topical treatments for psoriasis in 2009].
Topics: Administration, Cutaneous; Anthralin; Calcitriol; Dermatologic Agents; Drug Administration Schedule; | 2009 |
Efficacy and safety of treatments for childhood psoriasis: a systematic literature review.
Topics: Anthralin; Anti-Bacterial Agents; Calcineurin Inhibitors; Calcitriol; Child; Dermatologic Agents; Gl | 2010 |
[Children and adolescents with psoriasis. What therapy is recommended?].
Topics: Administration, Oral; Administration, Topical; Adolescent; Adrenal Cortex Hormones; Age Factors; Ant | 2012 |
Chronic plaque psoriasis.
Topics: Administration, Topical; Anthralin; Humans; Psoriasis; PUVA Therapy; Randomized Controlled Trials as | 2002 |
Chronic plaque psoriasis.
Topics: Administration, Topical; Anthralin; Humans; Psoriasis; PUVA Therapy; Retinoids; Ultraviolet Therapy; | 2002 |
A systematic review of adverse effects associated with topical treatments for psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Dermatologic Agen | 2003 |
Chronic plaque psoriasis.
Topics: Anthralin; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Ficusin; Humans; Nicotinic | 2004 |
Topical therapies for psoriasis: evidence-based review.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Dermatologic | 2005 |
Chronic plaque psoriasis.
Topics: Anthralin; Anti-Inflammatory Agents; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppress | 2005 |
[Dithranol in the treatment of scalp psoriasis].
Topics: Anthralin; Anti-Inflammatory Agents; Clinical Trials as Topic; Emulsions; Humans; Ointments; Patient | 2003 |
[Maintenance therapy of psoriasis].
Topics: Administration, Oral; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Combined Modalit | 2006 |
[Classical topical therapy of psoriasis].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Dermatologic Agents; Dose-Response Rel | 2006 |
Chronic plaque psoriasis.
Topics: Adrenal Cortex Hormones; Alefacept; Anthralin; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2006 |
Treatment of childhood psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Calcitriol; Child; Cyclosporine; Humans; Methotrexate; Nicotinic | 2006 |
[The immunology of psoriasis: from basic research to the bedside].
Topics: Acitretin; Adrenal Cortex Hormones; Alefacept; Anthralin; Antibodies, Monoclonal; Antibodies, Monocl | 2006 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; | 2007 |
Anthralin: historical and current perspectives.
Topics: Anthracenes; Anthralin; Cell Division; Chemistry; Cyclic AMP; Cyclic GMP; DNA Replication; Drug Admi | 1983 |
Animal assays for anti-psoriatic, retinoid and sun protective agents.
Topics: Adolescent; Adult; Animals; Anthralin; Coal Tar; DNA; Drug Evaluation, Preclinical; Fatty Acids, Ess | 1984 |
Psoriasis. A review of recent advances in treatment.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Coal Tar; Glucocorticoids; Humans; Hyd | 1984 |
[Psoriasis therapy with retinoid].
Topics: Anthralin; Cell Differentiation; Cell Division; Chemotaxis, Leukocyte; Drug Synergism; Drug Therapy, | 1982 |
Psoriasis and its treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Humans; Hydroxyurea; Methotrexate; Midd | 1981 |
Treatment of psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antimetabolites; Coal Tar; Furocoumari | 1980 |
Psoriasis: current advances in etiology and treatment.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antimetabolites; Cell Division; Coal T | 1981 |
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
Topics: Anthralin; Azathioprine; Carcinogens; Coal Tar; Humans; Hydroxyurea; Methotrexate; Mutagenicity Test | 1981 |
The uses of systemic chemotherapeutic agents in psoriasis.
Topics: Administration, Topical; Anthralin; Azathioprine; Azauridine; Chemical Phenomena; Chemistry; Humans; | 1981 |
International studies of the efficacy of etretinate in the treatment of psoriasis.
Topics: Anthralin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etretinate; Hum | 1982 |
Psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antimetabolites; Day Care, Medical; Di | 1982 |
Therapeutic progress. II: Treatment of psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Combined Modality | 1994 |
Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
Topics: Anthracenes; Anthralin; Drug Design; Humans; Lipid Peroxidation; Lipoxygenase Inhibitors; Psoriasis; | 1995 |
Trends in topical psoriasis therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Humans; Psoriasis; Retinoid | 1994 |
Cytokine system as potential target for antipsoriatic therapy.
Topics: Anthralin; Cholecalciferol; Cyclosporine; Cytokines; Glucocorticoids; Humans; Keratinocytes; Psorias | 1994 |
[Treatment of psoriasis].
Topics: Adrenal Cortex Hormones; Anthralin; Combined Modality Therapy; Cyclosporine; Humans; Methotrexate; P | 1993 |
Topical therapy for psoriasis.
Topics: Administration, Cutaneous; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cholecalcif | 1995 |
Tars and anthralins.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Drug Combinations; Humans; Photochemot | 1995 |
Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
Topics: Anthralin; Free Radicals; Humans; Inflammation Mediators; Psoriasis; Reactive Oxygen Species; Skin | 1997 |
Antipsoriatic anthrones: aspects of oxygen radical formation, challenges and prospects.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Dermatitis; DNA Damage; Enzyme Inhibit | 1996 |
The management of psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Cholecalcifer | 1998 |
Old wine in new bottles: the revival of anthralin.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Humans; Psoriasis | 1998 |
Topical psoriasis therapy.
Topics: Administration, Cutaneous; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Calcitriol; | 1999 |
Topical antipsoriatics.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Calcitriol; D | 2000 |
Better patient compliance in psoriasis.
Topics: Administration, Topical; Algorithms; Anthralin; Anti-Inflammatory Agents; Female; Humans; Male; Pati | 2000 |
Advances in psoriasis treatment.
Topics: Acitretin; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Coal Tar; Cyclosporine; Der | 2000 |
Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitr | 2001 |
Treatment of psoriasis. Part 1. Topical therapy and phototherapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Humans; Photo | 2001 |
Psoriasis of the scalp. Diagnosis and management.
Topics: Administration, Cutaneous; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antifungal | 2001 |
Managing the patient with psoriasis.
Topics: Administration, Oral; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Humans; Immunosu | 2001 |
Management of psoriasis.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal | 2001 |
Psoriasis: current concepts in management.
Topics: Administration, Topical; Adrenal Cortex Hormones; Age Factors; Anthralin; Ficusin; Glycogen; Hair; H | 1977 |
Psoriasis: a review. II.
Topics: Adrenal Cortex Hormones; Anthralin; Azathioprine; Azauridine; Fluorouracil; Humans; Hydroxyurea; Lom | 1975 |
[Antipsoriatic effect of dithranol (anthralin). 2].
Topics: Animals; Anthracenes; Anthralin; Cell Division; Cells, Cultured; Drug Antagonism; Humans; Mice; Muta | 1975 |
Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris.
Topics: Anthralin; Betamethasone; Calcitriol; Calcium; Cell Differentiation; Cell Division; Combined Modalit | 1992 |
Psoriatic research in China.
Topics: Administration, Cutaneous; Administration, Oral; Adrenal Cortex Hormones; Anthralin; China; Drugs, C | 1992 |
Dithranol allergy: fact or fiction?
Topics: Anthralin; Coal Tar; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male; Middle Aged; Psoria | 1992 |
Development of anthralin short-contact therapy in psoriasis: survey of published clinical trials.
Topics: Anthralin; Humans; Meta-Analysis as Topic; Psoriasis; Time Factors | 1992 |
The history of dithranol and related hydroxyanthrones, their efficacy, side effects, and different regimens employed in the treatment of psoriasis. A review.
Topics: Anthralin; Humans; Psoriasis | 1992 |
[Treatment of psoriasis using dithranol].
Topics: Anthralin; Dose-Response Relationship, Drug; Humans; Psoriasis; PUVA Therapy | 1992 |
Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris.
Topics: Anthralin; Humans; Psoriasis | 1990 |
The treatment of psoriasis.
Topics: Administration, Oral; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Bed Rest; Chroni | 1990 |
[Urea in combination with dithranol in treating psoriasis vulgaris].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Drug Therapy, Combination; Glucocortic | 1989 |
Drugs in exacerbation of psoriasis.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Anthralin; Anti-Inflammatory Agents, Non-Stero | 1986 |
ABC of dermatology. Treatment of psoriasis.
Topics: Administration, Topical; Anthralin; Coal Tar; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Ther | 1987 |
A retrospective study of the inpatient treatment of psoriasis with dithranol.
Topics: Anthralin; Humans; Length of Stay; Psoriasis; Retrospective Studies | 1987 |
Psoriasis Day Care Center at Stanford. Part-time and full-time programs.
Topics: Academic Medical Centers; Ambulatory Care; Anthralin; Day Care, Medical; Drug Administration Schedul | 1987 |
Combination phototherapy--a critical appraisal.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anthralin; Coal Tar; Combined Modality Th | 1986 |
[Use of autoradiography. Studies of cell kinetics in normal and psoriatic epidermis as an aid in decision making in therapeutic management].
Topics: Anthralin; Autoradiography; Cell Cycle; DNA; DNA Replication; Epidermal Cells; Epidermis; Humans; Ps | 1985 |
PUVA combination therapy.
Topics: Adrenal Cortex Hormones; Anthralin; Combined Modality Therapy; Humans; Methotrexate; Phototherapy; P | 1985 |
118 trials available for anthralin and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Relationship between Histological and Clinical Course of Psoriasis: A Pilot Investigation by Reflectance Confocal Microscopy during Goeckerman Treatment.
Topics: Anthralin; Capillaries; Castor Oil; Coal Tar; Female; Humans; Male; Microscopy, Confocal; Middle Age | 2016 |
Targeted 307 nm UVB-excimer light vs. topical dithranol in psoriasis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anthralin; Dermatologic Agents; Female; Hum | 2012 |
Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anthralin; Dermatologic Agents; Female; Hum | 2012 |
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial).
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Anthralin; Dermatologic Agents; Double-Bl | 2013 |
Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol.
Topics: Administration, Topical; Adult; Aged; Anthralin; Calcitriol; Combined Modality Therapy; Female; Huma | 2012 |
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Affinity Labels; Aged; Anthralin; Anti-Inflammatory Agen | 2002 |
Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment.
Topics: Administration, Topical; Adult; Ambulatory Care; Anthralin; Anti-Inflammatory Agents; Combined Modal | 2002 |
Twice-daily vs. once-daily inpatient dithranol for psoriasis.
Topics: Administration, Cutaneous; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anth | 2002 |
Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Calcitriol; Calcium Channel Ago | 2003 |
Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients.
Topics: Administration, Oral; Adolescent; Adult; Anthralin; Anti-Infective Agents; Biomarkers; Dietary Suppl | 2003 |
Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care; Anthralin; Anti-Inflammatory Agen | 2003 |
[Health economic aspects of psoriasis therapy. Is inpatient topical treatment of plaque-type psoriasis in this age of biologics still appropriate from both medical and economic viewpoints?].
Topics: Adult; Anthralin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Co | 2005 |
The effect of treatment on quality of life in psoriasis patients.
Topics: Ambulatory Care; Anthralin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Netherl | 2005 |
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
Topics: Adult; Aged; Aged, 80 and over; Anthralin; Calcitriol; Day Care, Medical; Dermatologic Agents; Drug | 2006 |
In search for new antipsoriatic agents: NAD topical composition.
Topics: Administration, Topical; Adult; Anthralin; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Stab | 2007 |
A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
Topics: Adult; Anthralin; Dermatologic Agents; Double-Blind Method; Drug Compounding; Female; Humans; Liposo | 2007 |
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
Topics: Administration, Topical; Anthralin; Calcitriol; Day Care, Medical; Dermatologic Agents; Drug Adminis | 2008 |
The treatment of active chronic psoriasis: a comparison of the effectiveness of a preparation containing 0.1% dithranol and 17% urea in a cream base and 0.1% dithranol in Lassar's past B.P.C.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Female; | 1981 |
Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
Topics: Anthracenes; Anthralin; Drug Evaluation; Humans; Psoriasis | 1984 |
Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses.
Topics: Adult; Aged; Anthracenes; Anthralin; Drug Administration Schedule; Female; Humans; Irritants; Male; | 1984 |
An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children.
Topics: Administration, Topical; Adolescent; Anthracenes; Anthralin; Child; Child, Preschool; Clinical Trial | 1983 |
[A new dithranol cream compared to placebo and ultraviolet therapy in the treatment of psoriasis].
Topics: Adolescent; Adult; Anthracenes; Anthralin; Clinical Trials as Topic; Double-Blind Method; Female; Hu | 1983 |
A comparative study of dithranol cream, 0.25% and 0.1%, and dithranol ointment 0.25% in the treatment of psoriasis.
Topics: Adolescent; Adult; Anthracenes; Anthralin; Clinical Trials as Topic; Female; Humans; Male; Middle Ag | 1983 |
Short-contact modification of the Ingram regime.
Topics: Administration, Topical; Anthracenes; Anthralin; Coal Tar; Humans; Ointments; Psoriasis; Time Factor | 1984 |
Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Betamethasone; Female; Humans; Male; M | 1984 |
Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis.
Topics: Administration, Topical; Adult; Ambulatory Care; Anthracenes; Anthralin; Bandages; Chronic Disease; | 1984 |
Short-contact dithranol therapy--a comparison with the Ingram regime.
Topics: Administration, Topical; Anthracenes; Anthralin; Coal Tar; Humans; Psoriasis; Time Factors; Ultravio | 1984 |
The treatment of chronic psoriasis in general practice: a multicentre trial.
Topics: Anthralin; Betamethasone Valerate; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; | 1982 |
A double-blind comparison of 0.1% dithranol and 17% urea (Psoradrate cream) and 0.25%-dithranol in vanishing cream (Dithrocream) in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; Double-Blind Method; Fema | 1982 |
Relapse rate and long-term management of plaque psoriasis after treatment with photochemotherapy and dithranol.
Topics: Adult; Anthracenes; Anthralin; Clinical Trials as Topic; Female; Humans; Male; Photochemotherapy; Ps | 1981 |
A comparative study of the therapeutic effect of dithranol cream 0.1% and 0.25% with that of dithranol stylus 0.1% and 0.2% in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Dosage Forms; Drug Evaluation; Emulsions; Humans; M | 1983 |
Dithrocream in psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Double-B | 1980 |
The treatment of chronic psoriasis a two-centre comparative study.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Coal Tar | 1981 |
A multicentre general practice study to compare Psoradrate 0.1% and Dithrocream 0.1% in the treatment of chronic psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Chronic Disease; Clinical Trials as Topic; Dermatol | 1982 |
International studies of the efficacy of etretinate in the treatment of psoriasis.
Topics: Anthralin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etretinate; Hum | 1982 |
Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study.
Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; Double-Blind | 1982 |
The effectiveness of low-strength anthralin in psoriasis. A paired comparison study.
Topics: Administration, Oral; Anthracenes; Anthralin; Double-Blind Method; Erythema; Female; Humans; Male; P | 1982 |
Clearance of chronic plaque psoriasis by anthralin-subjective and objective assessment and comparison with photochemotherapy.
Topics: Anthralin; Chronic Disease; Humans; Photochemotherapy; Psoriasis; PUVA Therapy | 1981 |
Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis.
Topics: Adolescent; Adult; Aged; Animals; Anthracenes; Anthralin; DNA; Female; Humans; Male; Mice; Mice, Hai | 1981 |
Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis.
Topics: Administration, Topical; Adult; Anthralin; Cell Adhesion Molecules; Combined Modality Therapy; E-Sel | 1994 |
Remission of ordinary psoriasis following a short clearance course of cyclosporin.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Anthralin; Arthritis; Blood | 1995 |
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; | 1995 |
Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Ps | 1993 |
A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris.
Topics: Adult; Aged; Anthralin; Capsules; Cell Differentiation; Cell Division; Epidermis; Female; Humans; Im | 1996 |
A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care Facilities; Anthralin; Anti-Inflam | 1998 |
Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment.
Topics: Administration, Topical; Adolescent; Adult; Anthralin; Anti-Inflammatory Agents; Enzyme-Linked Immun | 1998 |
The effectiveness of modified ingram therapy compared with severity of psoriasis.
Topics: Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Combined Modality Therapy | 1998 |
[Mometasone and calcipotriol optimize the initial therapeutic effect of dithranol in chronic persistent psoriasis].
Topics: Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Calcitriol; Dermatologic | 1998 |
Topical anthralin therapy for refractory nail psoriasis.
Topics: Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Female; Humans; Male; Mid | 1998 |
Low-dose narrow-band UVB phototherapy combined with topical therapy is effective in psoriasis and does not inhibit systemic T-cell activation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Balneology; C | 1998 |
A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis.
Topics: Activities of Daily Living; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Calcitriol | 1998 |
Concentration of an epidermal growth factor in blood serum of males during topical treatment of psoriasis.
Topics: Acute Disease; Administration, Cutaneous; Administration, Topical; Anthralin; Anti-Inflammatory Agen | 1999 |
Effects of Mahonia aquifolium ointment on the expression of adhesion, proliferation, and activation markers in the skin of patients with psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; CD3 Complex; HLA-DR Antigens; Humans; | 1999 |
[Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis].
Topics: Anthralin; Chronic Disease; Dermatologic Agents; Drug Combinations; Drug Synergism; Female; Gels; Hu | 1999 |
Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Combined Modality Therapy; Dose | 2000 |
Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Attitude; Calcitriol; Dermatologic Age | 2000 |
The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Calcitriol; Eczema; Emulsions; | 2000 |
The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Division; Clobetasol; Drug Admini | 2001 |
Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitr | 2001 |
Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
Topics: Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Clobetasol; Drug Administ | 2002 |
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis.
Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Anthralin; Calcitriol; Dose-Response Rel | 2002 |
Low strength anthralin in psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; Drug Therapy, Combination | 1979 |
Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anthracenes; Anthralin; Chronic Di | 1979 |
A topical treatment program for psoriasis with low anthralin concentrations.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Child, Preschool; C | 1977 |
A double-blind comparison of 0.1% dithranol in a 17% urea base ("Psoradrate") and base alone in the treatment of active chronic psoriasis.
Topics: Adolescent; Adult; Anthracenes; Anthralin; Child; Clinical Trials as Topic; Double-Blind Method; Dru | 1978 |
A randomized, controlled clinical trial comparing photochemotherapy with dithranol in the initial treatment of chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; Female; Humans; Male; Met | 1978 |
Dithranol cream.
Topics: Anthracenes; Anthralin; Clinical Trials as Topic; Drug Stability; Humans; Ointments; Psoriasis | 1979 |
Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis.
Topics: Adult; Anthralin; Coal Tar; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Methoxsalen; | 1978 |
[Oral psoriasis treatment with a new aromatic retinoid (Ro 10-9359): a multi-centre controlled study of 291 patients (preliminary results) (author's transl)].
Topics: Administration, Oral; Adolescent; Adult; Anthralin; Child; Female; Humans; Male; Middle Aged; Psoria | 1978 |
Relapse rate of psoriasis worsened by adding steroids to a dithranol regime.
Topics: Anthracenes; Anthralin; Betamethasone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; | 1976 |
[Therapy of psoriasis by ultraviolet-anthralin combination. A method for the general practitioner. 308 treated cases].
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Child, Preschool; Clinical Trials as Topic; | 1976 |
The influence of treatment of the paralesional skin with dithranol on healing in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; | 1975 |
Simplified dithranol treatment for psoriasis.
Topics: Anthracenes; Anthralin; Bandages; Baths; Clinical Trials as Topic; Drug Compounding; Female; Hospita | 1975 |
One-minute dithranol therapy in psoriasis: a placebo-controlled paired comparative study.
Topics: Adolescent; Adult; Aged; Anthralin; Chronic Disease; Double-Blind Method; Drug Administration Schedu | 1992 |
A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis.
Topics: Adult; Anthralin; Calcitriol; Calcium; Double-Blind Method; Female; Humans; Male; Observer Variation | 1992 |
[Correlations between the properties and effects of clinical therapy using textile material with antipsoriatic action].
Topics: Administration, Cutaneous; Adult; Aged; Anthralin; Biological Availability; Dose-Response Relationsh | 1992 |
Clinical studies with a novel dithranol formulation (Micanol) in combination with UVB at day-care centres.
Topics: Adolescent; Adult; Aged; Anthralin; Day Care, Medical; Female; Humans; Male; Middle Aged; Patient Sa | 1992 |
Short-contact treatment at home with Micanol.
Topics: Administration, Topical; Anthralin; Home Nursing; Humans; Psoriasis | 1992 |
An open, parallel groups, study of the importance of thoroughness of application in the treatment of psoriasis with a dithranol cream (Micanol).
Topics: Administration, Topical; Adult; Aged; Anthralin; Female; Humans; Male; Middle Aged; Ointments; Psori | 1992 |
A novel dithranol formulation in the over night treatment of psoriasis at home.
Topics: Adult; Aged; Aged, 80 and over; Anthralin; Female; Home Nursing; Humans; Male; Middle Aged; Psoriasi | 1992 |
Short- and long-contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis.
Topics: Adult; Aged; Anthralin; Female; Humans; Male; Middle Aged; Psoriasis | 1992 |
In vitro and in vivo comparison of creams containing dithranol 0.5%.
Topics: Animals; Anthralin; Double-Blind Method; Female; Humans; Irritants; Male; Ointments; Psoriasis; Rabb | 1991 |
Epidermal calmodulin levels in psoriasis before & after therapy.
Topics: Adolescent; Adult; Aged; Anthralin; Calmodulin; Drug Administration Schedule; Epidermis; Female; Hum | 1991 |
The effect of oral indomethacin on psoriasis treated with the Ingram regime.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anthralin; Chronic Disease; Coal Tar; Double-Blind Me | 1991 |
The effect of clobetasol-17-propionate and crude coal tar on dithranol-induced inflammation. A clinical and biochemical study.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anthralin; Clobetasol; Coal Tar; Drug Therapy, Combination; | 1990 |
The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Double-Blind Method; Drug Eruptions; Ethanolamines; Female; Huma | 1990 |
[The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Betamethasone; Drug Administration Sch | 1990 |
Ambulatory treatment of psoriasis with short-contact Dithrocream therapy: a multicenter study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anthralin; C | 1990 |
[Effect of an anthralin-containing hydrocolloid dressing in psoriasis vulgaris].
Topics: Adult; Anthralin; Bandages, Hydrocolloid; Colloids; Dose-Response Relationship, Drug; Female; Humans | 1990 |
Irritation and staining by 10-butyryl dithranol (butantrone) in psoriasis.
Topics: Adolescent; Adult; Anthralin; Clinical Trials as Topic; Drug Eruptions; Female; Humans; Male; Middle | 1986 |
Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
Topics: Administration, Topical; Adult; Anthralin; Clinical Trials as Topic; Female; Humans; Irritants; Male | 1987 |
Comparison of dithranol and butantrone in short contact therapy of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Clinical Trials as Topic; Female; Human | 1987 |
The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams.
Topics: Adolescent; Adult; Anthralin; DNA; Double-Blind Method; Erythema; Female; Flow Cytometry; Humans; Ke | 1988 |
Low concentration dithranol and coal tar (Psorin) in psoriasis: a comparison with alcoholic coal tar extract and allantoin (Alphosyl).
Topics: Adolescent; Adult; Aged; Allantoin; Anthralin; Coal Tar; Dermatologic Agents; Drug Combinations; Dru | 1989 |
Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
Topics: Adolescent; Adult; Aged; Anthralin; Combined Modality Therapy; Drug Compounding; Erythema; Female; H | 1989 |
[Low-dose dithranol in psoriasis of the face].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Clinical Trials as Topic; Dose-Response | 1989 |
Short contact dithranol therapy: advantages of a stiff emulsifying ointment base.
Topics: Adolescent; Adult; Anthralin; Clinical Trials as Topic; Excipients; Female; Humans; Male; Middle Age | 1989 |
Effect of UVB therapy and a coal tar bath on short contact dithranol treatment for psoriasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Clinical Trials as Topic; Coal Tar; Female; H | 1988 |
Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Com | 1988 |
Phototherapy and dithranol treatment of psoriasis: new lamps for old.
Topics: Adolescent; Adult; Anthralin; Clinical Trials as Topic; Combined Modality Therapy; Erythema; Female; | 1987 |
[Treatment of psoriasis with erythema dose of cygnoline and irradiation with ultraviolet rays].
Topics: Adolescent; Adult; Anthralin; Erythema; Female; Humans; Male; Middle Aged; Psoriasis; PUVA Therapy; | 1986 |
[Ambulatory external treatment of psoriasis vulgaris: comparison of the effectiveness of a dithranol and a glucocorticoid-containing preparation].
Topics: Administration, Topical; Adult; Anthralin; Clinical Trials as Topic; Desoximetasone; Dexamethasone; | 1988 |
The importance of the coal tar bath in the Ingram treatment of psoriasis. Evaluation by evaporimetry and laser Doppler flowmetry.
Topics: Adolescent; Adult; Aged; Anthralin; Blood Flow Velocity; Coal Tar; Combined Modality Therapy; Female | 1988 |
Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Betamethasone; Chronic Disease; Clobetasol; Coal Tar; Combined M | 1988 |
Combined short contact crude coal tar and dithranol therapy for psoriasis.
Topics: Anthralin; Clinical Trials as Topic; Coal Tar; Drug Therapy, Combination; Humans; Psoriasis | 1986 |
The effects of concomitant administration of oral indomethacin with topical dithranol treatment in psoriasis.
Topics: Adolescent; Adult; Anthralin; Drug Therapy, Combination; Female; Humans; Indomethacin; Male; Middle | 1987 |
Psoriasis treatment: faster clearance when UVB-dithranol is combined with topical clobetasol propionate.
Topics: Administration, Topical; Adult; Anthracenes; Anthralin; Betamethasone; Clobetasol; Combined Modality | 1986 |
Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Combined Modality Therapy; Erythema; Female; Humans | 1986 |
Treatment of psoriasis with dithranol cream compared with dithranol paste.
Topics: Administration, Topical; Anthralin; Dosage Forms; Erythema; Evaluation Studies as Topic; Humans; Pso | 1986 |
Treatment of psoriasis with a combination of dithranol and coal tar.
Topics: Anthralin; Coal Tar; Drug Therapy, Combination; Humans; Psoriasis | 1987 |
Comparison of a cream containing 0.1% dithranol in a 17% urea base (Psoradrate) with coal tar pomade in the treatment of scalp psoriasis.
Topics: Adult; Anthracenes; Anthralin; Clinical Trials as Topic; Coal Tar; Female; Humans; Male; Middle Aged | 1985 |
Out-patient treatment of psoriasis: short contact and overnight dithranol therapy compared.
Topics: Ambulatory Care; Anthracenes; Anthralin; Clinical Trials as Topic; Drug Administration Schedule; Hum | 1985 |
A comparison between Antraderm stick (0.5% and 1%) and dithranol paste (0.125% and 0.25%) in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; | 1985 |
Ambulatory treatment of psoriasis with dithranol sticks--a novel paraffin formulation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Clinical Trials as Topic; | 1985 |
Short contact dithranol therapy--twice daily and high concentration regimes.
Topics: Anthracenes; Anthralin; Drug Administration Schedule; Humans; Psoriasis | 1985 |
A comparison of Antraderm stick 1% and 2% with dithranol paste 0.25% and 0.5% respectively in the treatment of psoriasis.
Topics: Adult; Aged; Anthracenes; Anthralin; Consumer Behavior; Female; Humans; Male; Middle Aged; Ointments | 1985 |
Anthralin minute entire skin treatment. A new outpatient therapy for psoriasis.
Topics: Aged; Anthracenes; Anthralin; Female; Humans; Male; Methods; Middle Aged; Ointments; Outpatients; Ps | 1985 |
Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy.
Topics: Anthracenes; Anthralin; Drug Evaluation; Humans; Psoriasis; Ultraviolet Therapy | 1985 |
372 other studies available for anthralin and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
Topics: Administration, Topical; Animals; Anthracenes; Anti-Inflammatory Agents; Antioxidants; Cattle; Cell | 1994 |
Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8-dihydroxy-9-oxo-2-anthracenecarboxylic and -hydroxamic acids.
Topics: Animals; Antioxidants; Carboxylic Acids; Cattle; Cell Line; Humans; Hydroxamic Acids; Hydroxyl Radic | 1997 |
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non | 1997 |
10-omega-phenylalkyl-9(10H)-anthracenones as inhibitors of keratinocyte growth with reduced membrane damaging properties.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Division; Cell Line; Cell Membran | 1998 |
Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Division; Cell Line; Humans; Kera | 1999 |
Heterocyclic substituted anthralin derivatives as inhibitors of keratinocyte growth and inducers of differentiation.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Differentiation; Cell Division; C | 2001 |
Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
Topics: Acetanilides; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Divis | 2001 |
Structure-activity relationship studies of acridones as potential antipsoriatic agents. 1. Synthesis and antiproliferative activity of simple N-unsubstituted 10H-acridin-9-ones against human keratinocyte growth.
Topics: Acridines; Acridones; Biphenyl Compounds; Cell Line; Cell Membrane; Cell Proliferation; Humans; Kera | 2010 |
Structure-activity relationship studies of acridones as potential antipsoriatic agents. 2. Synthesis and antiproliferative activity of 10-substituted hydroxy-10H-acridin-9-ones against human keratinocyte growth.
Topics: Acridones; Cell Proliferation; Cells, Cultured; Humans; Keratinocytes; Psoriasis; Structure-Activity | 2010 |
Synthesis and structure-activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho[2,3-b]furan-4,9-diones, activation by enzymatic one- and two-electron reduction, and intracellular genera
Topics: Cell Line; Cell Membrane; Cell Proliferation; Dermatologic Agents; Dicumarol; Furans; Humans; Kerati | 2012 |
Design and synthesis of EGFR dimerization inhibitors and evaluation of their potential in the treatment of psoriasis.
Topics: Antioxidants; Apoptosis; Cell Line; Cell Proliferation; Dermatologic Agents; Drug Design; ErbB Recep | 2012 |
Successful removal of anthralin staining from facial skin.
Topics: Anthralin; Face; Humans; Psoriasis; Skin; Staining and Labeling | 2023 |
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiov | 2020 |
[Dithranol].
Topics: Anthralin; Cell Proliferation; Dermatologic Agents; Drug Combinations; Humans; Psoriasis | 2017 |
Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Topics: Administration, Cutaneous; Anthralin; Apoptosis; beta-Defensins; Biopsy; Cell Differentiation; Cell | 2017 |
Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Topics: Administration, Cutaneous; Animals; Anthralin; Dermatologic Agents; Disease Models, Animal; Drug Car | 2019 |
Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.
Topics: Adrenal Cortex Hormones; Anthralin; Antibodies, Monoclonal; Brazil; Calcineurin Inhibitors; Comorbid | 2019 |
Improving outcomes in patients with psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Calcineurin Inhibitors; Calcitriol; Dermatologic Agents; Humans; | 2013 |
An investigation of the effects of dithranol-induced apoptosis in a human keratinocyte cell line.
Topics: Anthralin; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biological Transport; Biomarkers; Cas | 2013 |
Hyperbranched dendritic nano-carriers for topical delivery of dithranol.
Topics: Administration, Cutaneous; Animals; Anthralin; Biological Availability; Dendrimers; Drug Carriers; H | 2013 |
The effectiveness and safety of short-contact dithranol therapy in paediatric psoriasis: a prospective comparison of regular day care and day care with telemedicine.
Topics: Adolescent; Anthralin; Child; Child, Preschool; Day Care, Medical; Dermatologic Agents; Drug Adminis | 2014 |
Innovation in dermatology.
Topics: Anthralin; Dermatologic Agents; Female; Humans; Male; Psoriasis | 2014 |
Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry.
Topics: Adolescent; Anthralin; Body Surface Area; Child; Child, Preschool; Dermatologic Agents; Female; Huma | 2015 |
Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Dermatologic Agents; Female; Hospitalization; | 2015 |
Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells.
Topics: Anthralin; Cell Line; Cell Proliferation; Gas Chromatography-Mass Spectrometry; Humans; Inflammation | 2015 |
Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.
Topics: Adolescent; Adult; Age Distribution; Aged; Anthralin; Austria; Dermatologic Agents; Female; Health C | 2015 |
Next-generation antipsoriatic drugs: small molecules join.
Topics: Anthralin; Dermatologic Agents; Humans; Psoriasis | 2015 |
Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Case-Control Studies; Cytokine TWEAK; Female; | 2016 |
Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anthralin; Fatty Acid Binding Protein 3; Fa | 2017 |
Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions.
Topics: Anthralin; Betamethasone; Dermatologic Agents; Female; Glucocorticoids; Humans; Psoriasis; Young Adu | 2009 |
Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
Topics: Administration, Topical; Adult; Anthralin; Case-Control Studies; Humans; Male; Middle Aged; Psoriasi | 2009 |
Childhood psoriasis: often favorable outcome.
Topics: Acitretin; Administration, Topical; Anthralin; Calcitriol; Child; Cyclosporine; Dermatologic Agents; | 2009 |
Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Anthralin; Child; Child, Preschool; De | 2010 |
Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assay.
Topics: Anthralin; Anti-Infective Agents, Local; Caspase 3; Caspase 7; Cell Line; Cell Proliferation; Colori | 2010 |
Therapy of psoriasis in childhood and adolescence - a German expert consensus.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adrenal Cortex Hormones; Anthralin; Anti- | 2011 |
Eosinophilia during psoriasis treatment with TNF antagonists.
Topics: Adalimumab; Anthralin; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Therapy, Combina | 2011 |
Effects of the antipsoriatic drug dithranol on E2A and caspase-9 gene expression in vitro.
Topics: Anthralin; Basic Helix-Loop-Helix Transcription Factors; Caspase 9; Cell Line; Cell Proliferation; D | 2012 |
Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes.
Topics: Animals; Anthralin; Dermatologic Agents; Disease Models, Animal; Emulsions; Humans; Mice; Nanostruct | 2013 |
A novelliposomal formulation of dithranol for psoriasis: preliminary results.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Drug Carriers; Female; Humans; Liposom | 2002 |
[Phototherapy and photochemotherapy of inflammatory dermatoses].
Topics: Administration, Topical; Adolescent; Anthralin; Anti-Inflammatory Agents; Child; Combined Modality T | 2003 |
[Influence of dithranol therapy on clinical status and serum calcitonin concentrations in patients with common psoriasis].
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Calcitonin; Case-Control Studie | 2002 |
Recalcitrant psoriasis vulgaris associated with Laurence-Moon-Biedl syndrome.
Topics: Adrenal Cortex Hormones; Adult; Anthralin; Bardet-Biedl Syndrome; Drug Resistance, Multiple; Drug Th | 2003 |
[Treatment of 100 patients with psoriasis with dithranol].
Topics: Anthralin; Antifungal Agents; Fungicides, Industrial; Humans; Psoriasis | 1960 |
[On a new dosage form for cignolin in the treatment of psoriasis].
Topics: Anthralin; Anti-Infective Agents, Local; Humans; Psoriasis | 1962 |
HISTOLOGICAL CHANGES IN PSORIASIS TREATED WITH DITHRANOL.
Topics: Anthracenes; Anthralin; Humans; Psoriasis | 1964 |
Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
Topics: Acetylcysteine; Anthralin; Anti-Inflammatory Agents; Antioxidants; Catalase; Cells, Cultured; Electr | 2004 |
Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
Topics: Administration, Topical; Alopecia Areata; Animals; Anthralin; Anti-Inflammatory Agents; Cytokines; D | 2004 |
Interleukin 4 plasma levels in psoriasis vulgaris patients.
Topics: Adult; Anthralin; Female; Ficusin; Humans; Interleukin-4; Male; Methotrexate; Middle Aged; Photother | 2004 |
Linear naevoid psoriasis along lines of Blaschko.
Topics: Anthralin; Anti-Inflammatory Agents; Child, Preschool; Female; Humans; Hydrocortisone; Nevus; Ointme | 2004 |
Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Topics: Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Female; Humans; Inpatient | 2005 |
The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria.
Topics: Anthralin; Anti-Inflammatory Agents; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Cytochromes c; | 2005 |
Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Case-Contro | 2005 |
Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.
Topics: Acitretin; Anthralin; Calcitriol; Coal Tar; Combined Modality Therapy; Female; Humans; Keratolytic A | 2005 |
[Comment on the letter and response regarding "Treatment of psoriasis capilliti with Dethranol].
Topics: Anthralin; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; | 2004 |
[Reader's letter on Norbert Haas, Andrea Wulff-Woesten,W. Sterry and H. Meffert. The treatment of psoriasis capillitii with dithranol. JDDG 2003, 1:688-693].
Topics: Anthralin; Anti-Inflammatory Agents; Humans; Keratolytic Agents; Ointment Bases; Psoriasis; Salicyli | 2003 |
[Reader's letter on Norbert Haas, Andrea Wulff-Woesten, W. Steary and H. Meffert. The treatment of psoriasis capillitii with dithranol. JDDG 2003; 1:688-693].
Topics: Anthralin; Anti-Inflammatory Agents; Humans; Ointment Bases; Psoriasis; Scalp Dermatoses; Time Facto | 2003 |
Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin.
Topics: Animals; Anthralin; Dermatologic Agents; Face; Humans; Image Processing, Computer-Assisted; Inflamma | 2006 |
Altered expression of prohibitin in psoriatic lesions and its cellular implication.
Topics: Anthralin; Dermatologic Agents; Gene Expression Regulation; Humans; Keratinocytes; Prohibitins; Psor | 2007 |
[Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
Topics: Adrenal Cortex Hormones; Anthralin; Arthritis, Psoriatic; Biological Products; Cyclosporine; Dermato | 2007 |
Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues.
Topics: Anthracenes; Anthralin; Drug Eruptions; Edema; Erythema; Humans; Psoriasis; Skin; Structure-Activity | 1980 |
Quantitative studies on the reactions of psoriatic epidermis to treatment.
Topics: Anthralin; Coal Tar; Epidermis; Fluocinolone Acetonide; Humans; Occlusive Dressings; Pilot Projects; | 1980 |
Itch following photochemotherapy for psoriasis.
Topics: Adult; Anthralin; Female; Humans; Male; Middle Aged; Photochemotherapy; Pruritus; Psoriasis; PUVA Th | 1981 |
Irritation, staining and antipsoriatic activity of 10-acyl analogues of anthralin.
Topics: Anthracenes; Anthralin; Chemical Phenomena; Chemistry; Free Radicals; Humans; Irritants; Psoriasis; | 1981 |
Cytokinetic effects of anthralin on psoriatic keratinocytes.
Topics: Anthracenes; Anthralin; Cell Division; Epidermis; Humans; Keratins; Psoriasis | 1981 |
A novel wax stick preparation of anthralin.
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Waxes | 1982 |
Psoriasis treatment and a day-care centre: clinical aspects and an attempt at a cost-benefit analysis.
Topics: Adolescent; Adult; Aged; Anthralin; Child; Cost-Benefit Analysis; Day Care, Medical; Employment; Fem | 1982 |
Irritation and staining by dithranol (anthralin) and related compounds. IV. Visual estimation of erythema compared with contact thermometry and laser Doppler flowmetry.
Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Erythema; Humans; Lasers; Psoriasis; Rheol | 1983 |
Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
Topics: Anthracenes; Anthralin; Drug Administration Schedule; Erythema; Humans; Psoriasis; Skin; Staining an | 1984 |
The inflammatory response to anthralin.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Dose-Response Relationship, Drug; Drug Eruptions; F | 1984 |
The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis.
Topics: Anthracenes; Anthralin; Clobetasol; Cyclic AMP; Cyclic GMP; Epidermis; Humans; Psoriasis; Skin | 1980 |
Should general practitioners use dithranol?
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Family Practice; Female; Humans; Male; Middl | 1983 |
Should general practitioners use dithranol?
Topics: Anthracenes; Anthralin; Humans; Psoriasis | 1983 |
Antipsoriatic drugs as inhibitors of soybean lipoxygenase. A possible mode of action.
Topics: Anthralin; Arachidonate Lipoxygenases; Etretinate; Glycine max; Lipoxygenase Inhibitors; Mycophenoli | 1983 |
Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro.
Topics: Animals; Anthracenes; Anthralin; Anthraquinones; Arachidonate Lipoxygenases; Arachidonic Acid; Arach | 1983 |
Influence of prophylactic photochemotherapy on incidence of relapse of psoriasis cleared initially with dithranol.
Topics: Anthralin; Follow-Up Studies; Humans; Photochemotherapy; Psoriasis; PUVA Therapy; Recurrence | 1984 |
The inflammatory response to anthralin and its relation to aryl hydrocarbon hydroxylase.
Topics: Anthracenes; Anthralin; Aryl Hydrocarbon Hydroxylases; Dermatitis, Contact; Dose-Response Relationsh | 1981 |
Allergy to dithranol.
Topics: Anthracenes; Anthralin; Dermatitis, Contact; Drug Eruptions; Female; Humans; Patch Tests; Psoriasis | 1982 |
Does UV-A potentiate 'short contact' dithranol therapy?
Topics: Adolescent; Adult; Anthracenes; Anthralin; Chronic Disease; Drug Administration Schedule; Drug Combi | 1984 |
Free radicals and the treatment of psoriasis with special reference to dithranol.
Topics: Anthracenes; Anthralin; Free Radicals; Humans; Leukocytes; Lipid Peroxides; Oxidation-Reduction; Oxy | 1984 |
Anthralin therapy for psoriasis.
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Time Factors | 1984 |
Resistant childhood psoriasis: an analysis of patients seen in a day-care center.
Topics: Administration, Topical; Adolescent; Anthralin; Anti-Inflammatory Agents; Child; Child, Preschool; C | 1984 |
Toxicologic study of anthralin in an aqueous cream formulation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Blood Urea Nitrogen; Femal | 1984 |
Improvement of the efficacy and safety of oral methoxsalen photochemotherapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anthralin; Drug Therapy, Combination; Humans; Methotr | 1984 |
Psoriasis.
Topics: Anthralin; Coal Tar; Humans; Psoriasis | 1983 |
[Psoriasis vulgaris. 2. Problems of the psoriatic patient--therapeutic possibilities].
Topics: Anthralin; Etretinate; Heliotherapy; Humans; Psoriasis; PUVA Therapy | 1983 |
Topical treatment of psoriasis with dithranol.
Topics: Administration, Topical; Anthracenes; Anthralin; Combined Modality Therapy; Drug Administration Sche | 1984 |
Relationship between skin type and erythemal response to anthralin.
Topics: Adult; Anthracenes; Anthralin; Dose-Response Relationship, Drug; Erythema; Female; Humans; Male; Pso | 1983 |
[Dithranol-stick prescription for simplified ambulatory psoriasis therapy].
Topics: Administration, Topical; Ambulatory Care; Anthracenes; Anthralin; Drug Compounding; Humans; Psoriasi | 1983 |
[Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid].
Topics: Adrenal Cortex Hormones; Anthracenes; Anthralin; Cell Division; Drug Therapy, Combination; Female; H | 1983 |
[Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
Topics: Adrenal Cortex Hormones; Anthracenes; Anthralin; Erythema; Humans; Microscopy, Electron; Photometry; | 1983 |
Short-duration dithranol therapy for psoriasis.
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Time Factors | 1983 |
Irritancy of anthralin in patients with psoriasis and widespread vitiligo.
Topics: Anthracenes; Anthralin; Female; Humans; Middle Aged; Psoriasis; Vitiligo | 1984 |
Treatment of psoriasis with dithranol cream in general practice.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Anti-Inflammatory Agents; | 1984 |
Contact dermatitis to coal tar.
Topics: Adolescent; Adult; Anthracenes; Anthralin; Coal Tar; Dermatitis, Contact; Female; Humans; Patch Test | 1984 |
[Experiences with high-dosage short-term dithranol therapy of psoriasis].
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Female; Humans; Male; Middle Aged; Psoriasis; Time | 1984 |
[A new Cologne therapy scheme--addition of tar to cignoline-salicylic acid-white vaseline therapy in psoriasis vulgaris].
Topics: Adolescent; Adult; Anthracenes; Anthralin; Coal Tar; Drug Therapy, Combination; Female; Humans; Male | 1984 |
[The effect of a tar admixture to dithranol-salicylic-acid-white-petrolatum therapy on the cytokinetics of psoriasis].
Topics: Adolescent; Adult; Anthracenes; Anthralin; Autoradiography; Drug Combinations; Female; Humans; Kinet | 1984 |
[Experience with the "minute treatment" of psoriasis vulgaris].
Topics: Administration, Topical; Anthracenes; Anthralin; Humans; Ointments; Psoriasis | 1984 |
Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy.
Topics: Adult; Anthracenes; Anthralin; Aryl Hydrocarbon Hydroxylases; Coal Tar; Dermatitis, Contact; Dose-Re | 1984 |
[Modern psoriasis therapy].
Topics: Anthracenes; Anthralin; Dermatologic Agents; Humans; Psoriasis; PUVA Therapy | 1984 |
[Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
Topics: Adult; Anthracenes; Anthralin; Coal Tar; Dermatologic Agents; Drug Combinations; Female; Humans; Mal | 1984 |
[Suppression of cignolin-induced erythema by tar].
Topics: Anthracenes; Anthralin; Coal Tar; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Combin | 1984 |
[Polyamines in psoriasis].
Topics: Anthralin; Carboxy-Lyases; Chemical Phenomena; Chemistry; Double-Blind Method; Eflornithine; Humans; | 1980 |
Comparative effects of topical anthralin and difluoromethylornithine (alpha DFMO) on epidermal polyamine concentration in psoriasis.
Topics: Anthracenes; Anthralin; Eflornithine; Humans; Ornithine; Polyamines; Psoriasis; Skin | 1981 |
[Therapy of psoriasis].
Topics: Anthralin; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Therapy; Salicylates | 1983 |
Irritant reactions to dithranol in normal subjects and psoriatic patients.
Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Erythema; Humans; Indomethacin; Irritants; | 1983 |
[Experiences with 2 short-term anthralin therapy schedules].
Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care; Anthracenes; Anthralin; Drug Admi | 1983 |
Recent advances in the treatment of psoriasis.
Topics: Anthralin; Coal Tar; Drug Therapy, Combination; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Th | 1983 |
Dithranol-UV-A phototherapy (DUVA) for psoriasis: a treatment without dressings.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Female; Humans; Mal | 1983 |
[Psoriasis: the clinical use of "minute therapy" with Cignolin].
Topics: Administration, Topical; Anthracenes; Anthralin; Anti-Inflammatory Agents; Drug Evaluation; Humans; | 1983 |
[Study on the efficacy of a combined treatment of psoriasis with dithranol and UV-B (selective ultraviolet-phototherapy)].
Topics: Adolescent; Adult; Anthracenes; Anthralin; Evaluation Studies as Topic; Female; Humans; Male; Middle | 1983 |
[Psoradrate (dithranol) cream].
Topics: Administration, Topical; Anthracenes; Anthralin; Dermatologic Agents; Humans; Ointments; Psoriasis | 1983 |
[Linear psoriasis?].
Topics: Anthralin; Female; Humans; Middle Aged; Nevus, Pigmented; Psoriasis; Skin Neoplasms | 1983 |
Current trends in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Drug Therapy, Combination; Etretinate; Female; Humans; Male; Met | 1983 |
Anthralin inflammation versus UV-erythema in psoriatics.
Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Ery | 1983 |
Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis.
Topics: Anthralin; Cell Survival; Epidermal Cells; Hot Temperature; Humans; Hydrocortisone; In Vitro Techniq | 1983 |
Measurement of the response of psoriasis to short-term application of anthralin.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Burns, Chemical; Drug Admi | 1983 |
Treatment of chronic psoriasis by Psoradrate (0.1% dithranol in a 17% urea base) applied under occlusion.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Female; Humans; Male; Middle Aged; Occlusive Dressi | 1983 |
Psoriasis.
Topics: Anthralin; Furocoumarins; Humans; Methotrexate; Photochemotherapy; Psoriasis; United States | 1980 |
[Diseases in a dermatologic department and outpatient clinic. 1. Psoriasis is a disease one must learn to live with].
Topics: Anthralin; Hair Diseases; Humans; Psoriasis; PUVA Therapy; Radiotherapy; Steroids; Tars | 1980 |
Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Drug Administration Schedu | 1982 |
Treatment of psoriasis with the Ingram anthralin paste regimen.
Topics: Administration, Topical; Anthracenes; Anthralin; Humans; Ointments; Psoriasis; Recurrence; Surveys a | 1982 |
Psoriasis.
Topics: Alcoholism; Anthralin; Humans; Hydrocortisone; Patient Education as Topic; Psoriasis; Tars; Ultravio | 1982 |
Methotrexate maintenance following Ingram therapy in 'difficult' psoriasis.
Topics: Anthralin; Coal Tar; Female; Humans; Male; Methotrexate; Psoriasis; Retrospective Studies; Ultraviol | 1982 |
[Combined 1-hour therapy of psoriasis using anthralin and UV light].
Topics: Adult; Anthracenes; Anthralin; Female; Humans; Male; Middle Aged; Psoriasis; Ultraviolet Therapy | 1982 |
[One-hour-treatment of psoriasis with anthralin and UV-light (author's transl)].
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Ultraviolet Therapy | 1982 |
Anthralin and chrysarobin: a reexamination of the origins and early use.
Topics: Anthracenes; Anthralin; Anti-Inflammatory Agents; Humans; Psoriasis | 1982 |
Treatment of chronic psoriasis vulgaris.
Topics: Adrenal Cortex Hormones; Anthralin; Coal Tar; Humans; Methotrexate; Peritoneal Dialysis; Psoriasis; | 1982 |
[Demonstration of circulating immune complexes in the serum of psoriasis patients].
Topics: Adolescent; Adult; Aged; Anthralin; Antigen-Antibody Complex; Child; Humans; Male; Middle Aged; Prec | 1982 |
The management of psoriasis.
Topics: Anthralin; Humans; Methotrexate; Psoriasis; PUVA Therapy; Steroids, Fluorinated; Tars; Ultraviolet T | 1982 |
On the stability of some antipsoriatic active anthralin (dithranol) derivatives.
Topics: Anthracenes; Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Chromatography, High Pressure | 1982 |
Dithranol in a cream base in the treatment of psoriasis.
Topics: Anthracenes; Anthralin; Humans; Ointments; Psoriasis; PUVA Therapy | 1982 |
[Investigation of local therapy following urea pretreatment. First results (author's transl)].
Topics: Adolescent; Adult; Aged; Anthralin; Dexamethasone; Eczema; Female; Humans; Male; Middle Aged; Premed | 1981 |
Contact allergy to dithranol.
Topics: Adult; Anthracenes; Anthralin; Dermatitis, Contact; Female; Humans; Patch Tests; Psoriasis; Warts | 1981 |
[A very promising treatment method in psoriasis. Short-term anthralin therapy].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Drug Administration Schedu | 1981 |
Advances in the use of anthralin.
Topics: Anthracenes; Anthralin; Humans; Psoriasis | 1981 |
Current concepts in the mode of action of anthralin in the treatment of psoriasis.
Topics: Animals; Anthracenes; Anthralin; Humans; Psoriasis | 1981 |
Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
Topics: Anthracenes; Anthralin; Humans; Psoriasis | 1981 |
Innovative use of anthralin. An overview of past, present and future developments.
Topics: Anthracenes; Anthralin; Humans; Psoriasis | 1981 |
Editorial: anthralin--the challenge.
Topics: Anthracenes; Anthralin; Chemical Phenomena; Chemistry; Humans; Psoriasis | 1981 |
Pharmaceutical formulations of anthralin.
Topics: Anthracenes; Anthralin; Chemistry, Pharmaceutical; Humans; Paraffin; Psoriasis; Salicylates; Salicyl | 1981 |
New chemical stabilizers, vehicles and delivery systems to enhance efficacy of low strength anthralin formulations.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Chemistry, Pharmaceutical; | 1981 |
Structure specificity of the antipsoriatic anthrones.
Topics: Anthracenes; Anthralin; Dermatologic Agents; Humans; Psoriasis; Structure-Activity Relationship | 1981 |
Effect of anthralin on stratum corneum antigenicity and polymorphonuclear leukocyte chemotaxis.
Topics: Anthracenes; Anthralin; Antigens; Chemotaxis, Leukocyte; Epidermis; Humans; Neutrophils; Psoriasis | 1981 |
Antipsoriatic therapy and skin cancer.
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Skin Neoplasms | 1981 |
Ingram method: the precursor of photochemotherapy.
Topics: Anthracenes; Anthralin; Glucosephosphate Dehydrogenase; Humans; In Vitro Techniques; Oxygen Consumpt | 1981 |
Pharmacological studies of anthralin erythema.
Topics: Anthracenes; Anthralin; Aspirin; Betamethasone Valerate; Chlorpheniramine; Erythema; Female; Humans; | 1981 |
Factors influencing anthralin erythema.
Topics: Anthracenes; Anthralin; Erythema; Humans; Psoriasis; Skin; Ultraviolet Therapy | 1981 |
[Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
Topics: Adolescent; Adult; Anthracenes; Anthralin; Drug Combinations; Female; Humans; Male; Middle Aged; Pho | 1981 |
Impaired contact hypersensitivity in untreated psoriasis and the effects of photochemotherapy and dithranol/UV-B.
Topics: Adult; Aged; Anthralin; Dermatitis, Contact; Dinitrochlorobenzene; Dose-Response Relationship, Immun | 1981 |
[Local supplementary administration in PUVA therapy of psoriasis].
Topics: Administration, Topical; Anthralin; Baths; Humans; Photochemotherapy; Psoriasis; PUVA Therapy | 1981 |
Psoriasis.
Topics: Anthralin; Coal Tar; Folic Acid Antagonists; Humans; Psoriasis; PUVA Therapy; Vitamin A | 1981 |
Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy.
Topics: Administration, Topical; Anthracenes; Anthralin; Humans; Psoriasis; Time Factors | 1980 |
[Conventional therapeutic methods in psoriasis vulgaris].
Topics: Anthracenes; Anthralin; Female; Humans; Psoriasis | 1980 |
[Comparison of conventional external methods of therapy in psoriasis vulgaris].
Topics: Adult; Anthracenes; Anthralin; Female; Humans; Petrolatum; Psoriasis; Salicylates; Tars; Ultraviolet | 1980 |
Nitrogen mustard in skin ointment and Psorin.
Topics: Anthracenes; Anthralin; Chemistry, Pharmaceutical; Coal Tar; Dermatologic Agents; Drug Combinations; | 1980 |
Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy.
Topics: Anthralin; Coal Tar; Epidermis; Etretinate; Gene Expression; Humans; Immunohistochemistry; In Situ H | 1994 |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes.
Topics: Anthralin; Cell Line; Cyclosporine; Humans; Immunohistochemistry; Indoles; Intracellular Fluid; Kera | 1995 |
Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anthralin; CD8-Positive T-Lymphocytes; Cell | 1995 |
Up-regulation of p21WAF1/CIP1 in psoriasis and after the application of irritants and tape stripping.
Topics: Anthralin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Epidermis; Humans; Irritants; Physical St | 1995 |
Intolerance and contact allergy to tar and dithranol in psoriasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Coal Tar; Dermatitis, Allergic Contact; Drug | 1994 |
Efficacy of short-contact therapy with dithranol in childhood psoriasis.
Topics: Administration, Cutaneous; Adolescent; Anthralin; Child; Child, Preschool; Drug Tolerance; Female; F | 1994 |
Treatment of psoriasis by topical photodynamic therapy with polychromatic light.
Topics: Administration, Topical; Aminolevulinic Acid; Anthralin; Chronic Disease; Follow-Up Studies; Humans; | 1994 |
The systemic effect of dithranol treatment in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Humans; Laser-Doppler Flowmetry; Middle | 1994 |
The hyperperfusion of the psoriatic plaque correlates histologically with dilatation of vessels.
Topics: Anthralin; Humans; Image Processing, Computer-Assisted; Laser-Doppler Flowmetry; Psoriasis; Regional | 1994 |
Anthralin: how does it act and are there more favourable derivatives?
Topics: Anthralin; Humans; Psoriasis | 1994 |
The interleukin-8 receptor: a potential target for antipsoriatic therapy?
Topics: Anthralin; Calcitriol; Cells, Cultured; Cyclosporine; Flow Cytometry; HLA-DR Antigens; Humans; Inter | 1994 |
Down-regulation of epidermal growth factor receptors by dithranol.
Topics: Anthralin; Anthraquinones; Cell Line; Dose-Response Relationship, Drug; Epidermis; ErbB Receptors; H | 1993 |
Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels.
Topics: Adult; Anthralin; Antigens, CD; Cell Adhesion Molecules; Combined Modality Therapy; Humans; Intercel | 1993 |
Prescribing in psoriasis.
Topics: Anthralin; Calcitriol; Coal Tar; Cyclosporins; Humans; Methotrexate; Phototherapy; Psoriasis; Retino | 1994 |
Tumorigenicity of a combination of psoriasis therapies.
Topics: Adenosine Triphosphate; Administration, Topical; Animals; Anthralin; Benzo(a)pyrene; Carcinogens; Co | 1994 |
Psoriasis: therapeutic aspects.
Topics: Adrenal Cortex Hormones; Anthralin; Cyclosporins; Drug Costs; Emollients; Humans; Keratolytic Agents | 1993 |
Measurement of plaque thickness and evaporative water loss in psoriasis with PUVA and dithranol treatment.
Topics: Anthralin; Humans; Psoriasis; PUVA Therapy; Skin; Water Loss, Insensible | 1993 |
Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Catalase; Cell Line; Humans; | 1996 |
Effects of dithranol on neutrophil superoxide generation in patients with psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Culture Techniques; Female; Human | 1996 |
Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Anthralin; Antioxidants; Cattle; Cell Division; | 1996 |
The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Count; Cell Division; Cell Size; | 1996 |
Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
Topics: Administration, Cutaneous; Adult; Anthralin; Cell Differentiation; Chronic Disease; Epidermis; Femal | 1996 |
Anthranoid free radicals found in pseudomelanosis coli.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cathartics; Colon; Colonic Diseases; E | 1998 |
Effects of antipsoriatic therapies on hepatic microsomal enzyme activity in patients with psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antipyrine; Cytochrome P-450 Enzyme In | 1998 |
The Woronoff zone surrounding the psoriatic plaque.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Chronic Disease; Drug Eruptions; Femal | 1998 |
Comparison of actual psoriasis surface area and the psoriasis area and severity index by the human eye and machine vision methods in following the treatment of psoriasis.
Topics: Acitretin; Administration, Topical; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Calcitriol; Co | 1998 |
[Findings in children with psoriasis].
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Aspirin; Calcitriol; Child | 1999 |
Serum level of sELAM-1 in psoriatic patients correlates with disease activity.
Topics: Acute Disease; Administration, Cutaneous; Administration, Topical; Adult; Anthralin; Anti-Inflammato | 1999 |
A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Antigens, Viral; Calcitriol; Ca | 1999 |
Dithranol treatment of psoriasis in dithranol-sensitive patients.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Dermatitis, Allergic Contact; D | 1999 |
Allergic contact dermatitis from dithranol.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Dermatitis, Allergic Contact; Drug Hyp | 1999 |
The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration.
Topics: Adaptation, Physiological; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Case-Contro | 1999 |
Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Enzyme Activation; Humans; Infant, New | 2000 |
[White blood cell picture of the peripheral blood of psoriatic patients treated with PUVA and cignoline].
Topics: Administration, Topical; Adolescent; Adult; Anthralin; Anti-Inflammatory Agents; Basophils; Combined | 1997 |
Topical anthralin for psoriasis vulgaris: evaluation of 70 Japanese patients.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Female; Follo | 2000 |
Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Calcitriol; Cost-Benefit Analysis; Dec | 2000 |
Increased interleukin-7 levels in the sera of psoriatic patients: lack of correlations with interleukin-6 levels and disease intensity.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Anti-Inflammatory Agents; Cohort Studie | 2000 |
Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Baths; Calcitriol; Dermatologic | 2001 |
An unusual case of melanosis coli.
Topics: Aged; Anthralin; Biopsy; Colonic Diseases; Humans; Intestinal Mucosa; Lipofuscin; Male; Melanosis; P | 2001 |
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study.
Topics: Administration, Topical; Analysis of Variance; Anthralin; Anti-Inflammatory Agents; Calcitriol; Comp | 2001 |
[Nuclear factor kappa B (NF-kappa B). II. Pathophysiologic meaning].
Topics: Acute-Phase Reaction; Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Autoimm | 2001 |
Ingram method of treating psoriasis.
Topics: Administration, Topical; Anthralin; Dermatologic Agents; Humans; Psoriasis | 1965 |
Activity of Tumor Necrosis Factor-alfa (TNF-alpha) and selected acute phase proteins in plasma of psoriatic patients receiving local treatment.
Topics: Adult; alpha-Macroglobulins; Anthralin; C-Reactive Protein; Follow-Up Studies; Humans; Male; Middle | 2001 |
Dithranol for psoriasis.
Topics: Anthracenes; Anthralin; Chronic Disease; Cost-Benefit Analysis; Humans; Photochemotherapy; Psoriasis | 1979 |
Dithranol for psoriasis.
Topics: Anthracenes; Anthralin; Chronic Disease; Drug Evaluation; Humans; Ointments; Photochemotherapy; Psor | 1979 |
Dithranol or photochemotherapy for psoriasis?
Topics: Ambulatory Care; Anthracenes; Anthralin; Evaluation Studies as Topic; Humans; Photochemotherapy; Pso | 1979 |
Socioeconomic benefits of psoralen/ultraviolet therapy.
Topics: Anthralin; Disability Evaluation; Drug Evaluation; Female; Furocoumarins; Humans; Male; Photochemoth | 1979 |
Skin polyamine levels in psoriasis: the effect of dithranol therapy.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Female; Humans; Male; Middle Aged; Mitosis; Polyami | 1978 |
[How much of classical topical therapy is still current today? (author's transl)].
Topics: Administration, Topical; Anthralin; Balsams; Coal Tar; Humans; Psoriasis; Salicylates; Skin Diseases | 1979 |
Epidermal activity of NAD-dependent isocitrate dehydrogenase in psoriasis during treatment with dithranol.
Topics: Adolescent; Adult; Anthracenes; Anthralin; Humans; Isocitrate Dehydrogenase; Keratins; Keratosis; Mi | 1975 |
Psoriasis: a medical mystery?
Topics: Administration, Topical; Anthralin; Arthritis; Coal Tar; Cyclic AMP; Histocompatibility Antigens; Hu | 1978 |
Epidermal nicotinamide adenine dinucleotides in psoriasis during treatment with dithranol.
Topics: Adolescent; Adult; Anthracenes; Anthralin; Humans; Middle Aged; Mitochondria; NAD; NADP; Psoriasis; | 1975 |
Coexistent psoriasis and bullous pemphigoid: a report of six cases.
Topics: Aged; Anthralin; Dermatologic Agents; Female; Humans; Male; Middle Aged; Psoriasis; Skin Diseases, V | 1978 |
Psoriasis: topical and systemic therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Coal Tar; Humans; Hydroxyurea; Keratoly | 1979 |
Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Anthralin; Female; Humans; Male; Midd | 1979 |
[Skin impedance and phoreographic index in psoriasis. Relationship with action kinetics of three treatments].
Topics: Anthralin; Electric Conductivity; Fluprednisolone; Humans; Keratins; Kinetics; Methoxsalen; Mitotic | 1979 |
Dithranol creams for psoriasis.
Topics: Anthracenes; Anthralin; Humans; Ointments; Psoriasis | 1979 |
[Dithranol therapy of common psoriasis of the scalp].
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Scalp Dermatoses | 1979 |
Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment. A multicenter study of computerized data.
Topics: Administration, Oral; Administration, Topical; Alanine Transaminase; Alkaline Phosphatase; Anthralin | 1979 |
[Treatment of psoriasis with salicylic acid, tar and dithranol].
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Salicylates; Tars | 1979 |
Inhibition of human blood platelet aggregation by photochemotherapy in vitro and in vivo.
Topics: Adult; Anthralin; Collagen; Humans; Methoxsalen; Photochemotherapy; Platelet Aggregation; Psoriasis; | 1979 |
Photochemotherapy for psoriasis remission times. Psoralens and UV-A and combined photochemotherapy with anthralin.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Drug Therapy, Combination; Female; Humans; M | 1979 |
Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture.
Topics: Animals; Anthralin; Antimetabolites; Azauridine; Cell Division; Cells, Cultured; Cycloheximide; Cyta | 1978 |
[Conventional external therapy of psoriasis vulgaris].
Topics: Anthralin; Humans; Photochemotherapy; Psoriasis; Salicylates; Tars; Ultraviolet Therapy | 1978 |
Dermatology: psoriasis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anthralin; Child; Child, Preschool; Coal Tar; Epidermis; | 1978 |
[Activity studies of various serum enzymes in patients with psoriasis locally treated with dithranol].
Topics: Acid Phosphatase; Adult; Anthracenes; Anthralin; Female; Glucosephosphate Dehydrogenase; Humans; L-L | 1978 |
PUVA or dithranol?
Topics: Anthracenes; Anthralin; Ficusin; Humans; Photochemotherapy; Psoriasis | 1978 |
[Clinical and histological observations on psoriasis regression following cignoline treatment].
Topics: Adult; Anthracenes; Anthralin; Female; Humans; Male; Middle Aged; Mitosis; Psoriasis; Remission, Spo | 1978 |
[Drug information. Dithranol].
Topics: Anthracenes; Anthralin; Humans; Psoriasis | 1978 |
[A new method of local treatment of psoriasis].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Child, Preschool; D | 1979 |
Variation in the prevalence of antibiotic resistance of Staphylococcus aureus from human skin and nares.
Topics: Anthralin; Anti-Bacterial Agents; Desiccation; Drug Resistance, Microbial; Eczema; Ethidium; Female; | 1977 |
Controlling psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Arthritis; Coal Tar; Diagnosis, Differential; Humans; Methotrexa | 1977 |
Sister chromatid exchanges in photochemotherapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anthralin; Child; Chromatids; Chromosome Aberrations; DNA Repa | 1977 |
[Treatment of psoriasis using Cignolin (dihydroxyanthranol): CSP (Cignolin-Salicylic acid-Petrolatum) - treatment schedule from Cologne].
Topics: Anthracenes; Anthralin; Drug Prescriptions; Drug Synergism; Drug Therapy, Combination; Germany, West | 1976 |
[Response to W.H. Goeckermann's and I.T. Ingram's therapy for psoriasis vulgaris, guttata and arthropathica as well as their dependency on external factors (author's transl)].
Topics: Adolescent; Adult; Aged; Anthralin; Child; Child, Preschool; Female; Hospitalization; Humans; Infant | 1976 |
[PUVA and anthraline therapy of psoriasis, a clinical, histological and autoradiographic comparison].
Topics: Adult; Anthracenes; Anthralin; Coumarins; DNA; Female; Ficusin; Humans; Male; Middle Aged; Psoriasis | 1976 |
[Allophlogisty in several psoriasis patients].
Topics: Anthralin; Arthritis, Reactive; Humans; Immunologic Deficiency Syndromes; Psoriasis; Skin; Skin Test | 1976 |
Treatment of psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antineoplastic Agents; Glucocorticoids | 1976 |
Treatment of psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Coal Tar; Humans; Methotrexate; Methoxsalen; Psoriasis; Ultravio | 1976 |
[The treatment of psoriasis].
Topics: Adrenal Cortex Hormones; Anthralin; Humans; Liver; Methotrexate; Nitrogen Mustard Compounds; Ointmen | 1975 |
Psoralens for psoriasis.
Topics: Adolescent; Adult; Anthralin; Coumarins; Ficusin; Humans; Methoxsalen; Middle Aged; Psoriasis; Triox | 1975 |
[Antipsoriatic effect of dithranol (anthralin). 1].
Topics: Alkaline Phosphatase; Anthracenes; Anthralin; Cell Division; Chemical Phenomena; Chemistry; Dose-Res | 1975 |
Evaluation of dithranol and a 'synthetic tar' as anti-psoriatic treatments using the mouse tail test.
Topics: Animals; Anthracenes; Anthralin; Carbazoles; Cresols; Mice; Naphthalenes; Phenanthrenes; Phenols; Pi | 1975 |
Clobetasol propionate ointment compared with dithranol in Lassar's paste in the treatment of psoriasis.
Topics: Adolescent; Anthracenes; Anthralin; Betamethasone; Humans; Male; Psoriasis; Remission, Spontaneous | 1976 |
Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro.
Topics: Anthralin; Cell Division; ErbB Receptors; Humans; Insulin-Like Growth Factor I; Keratinocytes; Psori | 1992 |
Psoriasis symposium. Topical therapy.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cholecalciferol; Coal Tar; Dermatologi | 1992 |
B-scanning evaluation with image analysis of psoriatic skin.
Topics: Adult; Anthralin; Female; Humans; Image Processing, Computer-Assisted; Middle Aged; Psoriasis; Refer | 1992 |
Immunohistochemical study on the pattern of 50 kd cytokeratin in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone; Epid | 1992 |
A semiempirical computational investigation of the antipsoriatic drug anthralin.
Topics: Anthralin; Molecular Structure; Psoriasis | 1992 |
The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of action.
Topics: Animals; Anthralin; In Vitro Techniques; Male; Neutrophils; Protein Kinase C; Psoriasis; Rats; Rats, | 1992 |
Contact allergy to dithranol.
Topics: Adult; Anthralin; Drug Eruptions; Humans; Male; Patch Tests; Psoriasis | 1992 |
[The treatment of psoriasis with dithranol].
Topics: Anthralin; Drug Antagonism; Humans; Pharmaceutical Vehicles; Psoriasis; Zinc Oxide | 1992 |
A quantitative method for measuring antipsoriatic activity of drugs by the mouse tail test.
Topics: Animals; Anthralin; Drug Evaluation, Preclinical; Male; Mice; Mice, Inbred Strains; Psoriasis; Tail; | 1992 |
Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Anthralin; Anthraquinones; Cell Line; Down-Regulation; E | 1991 |
Keratin 17: a useful marker in anti-psoriatic therapies.
Topics: Anthralin; Antibodies, Monoclonal; Biomarkers; Calcitriol; Frozen Sections; Gene Expression; Humans; | 1991 |
Introduction of anthralin into dermatology.
Topics: Anthralin; Dermatology; Germany; History, 20th Century; Humans; Psoriasis | 1992 |
Psoriasis in childhood.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Child; Female; Humans; Male; Nails; Psoriasis; PUVA | 1992 |
[75 years of Cignolin].
Topics: Anthralin; Germany; History, 19th Century; History, 20th Century; Humans; Psoriasis | 1991 |
Anthralin derivatives--inhibition of 5-lipoxygenase--antipsoriatic efficacy.
Topics: Animals; Anthralin; Cattle; Chromatography, High Pressure Liquid; Humans; In Vitro Techniques; Lipox | 1991 |
Studies on the time course of dithranol-induced inflammation by quantification of alkaline phosphatase.
Topics: Adult; Alkaline Phosphatase; Anthralin; Biopsy; Erythema; Female; Free Radicals; Humans; Male; Patch | 1990 |
UVABA therapy for psoriasis. Efficacy with shortened treatment times with the combined use of coal tar, anthralin, and metal halide ultraviolet machines.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Coal Tar; Combined Modality Therapy; Female; | 1991 |
[Effect of tar and dithranol on fibrinolysis in treatment of psoriasis].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthralin; Coal Tar; Female; Fibrinolysis; Humans; | 1990 |
The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes.
Topics: Animals; Anthralin; Biomechanical Phenomena; Cell Membrane; Cyanobacteria; Energy Metabolism; Humans | 1990 |
Antipsoriatic therapies inhibit epidermal plasminogen activator activity.
Topics: Adult; Anthralin; Betamethasone Valerate; Biopsy; Female; Humans; Immunohistochemistry; Male; Middle | 1990 |
Reduction of anthralin-induced inflammation by application of amines.
Topics: Administration, Cutaneous; Adult; Aged; Amines; Anthralin; Drug Eruptions; Female; Humans; Hydroxide | 1990 |
Synthesis and characterization of new 10-acylderivatives of the antipsoriatic agent dithranol: coupling products of dithranol with all-trans-retinoic acid, 13-cis-retinoid acid and an aromatic analogue of retinoic acid: all-trans-9-(4-methoxy-2,3,6-trimet
Topics: Acitretin; Anthralin; Isotretinoin; Magnetic Resonance Spectroscopy; Psoriasis; Tretinoin | 1990 |
Studies on the contact sensitizing activity of dithranol (anthralin) and 10-butyryl dithranol (butantrone).
Topics: Animals; Anthralin; Dermatitis, Contact; Disease Models, Animal; Dose-Response Relationship, Immunol | 1990 |
Antioxidant and prooxidant effects of the antipsoriatic compound anthralin in skin and subcellular fractions.
Topics: Animals; Anthralin; Antioxidants; Energy Metabolism; Free Radicals; Mice; Mice, Hairless; Psoriasis; | 1990 |
Practical aspects of anthralin therapy.
Topics: Administration, Topical; Anthralin; Humans; Psoriasis | 1990 |
Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
Topics: Administration, Topical; Anthralin; Biopsy; Humans; Irritants; Keratinocytes; Langerhans Cells; Micr | 1990 |
Keratoses in patients with psoriasis: a prospective study in fifty-two inpatients.
Topics: Adult; Aged; Aged, 80 and over; Anthralin; Female; Follow-Up Studies; Humans; Keratosis; Male; Michi | 1990 |
[10-Acyldithranol dimers; new derivatives of the antipsoriatic dithranol; synthesis, characterization and biochemical properties].
Topics: Anthralin; Chemical Phenomena; Chemistry; Glucosephosphate Dehydrogenase; Magnetic Resonance Spectro | 1990 |
[Simplified short-term dithranol therapy--on/off schedule].
Topics: Administration, Topical; Anthralin; Drug Administration Schedule; Humans; Psoriasis | 1990 |
Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
Topics: Adenosine Triphosphatases; Adult; Aged; Anthracenes; Anthralin; Antibodies, Monoclonal; Cell Count; | 1985 |
Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
Topics: Anthralin; Dose-Response Relationship, Drug; Humans; Irritants; Psoriasis; Regional Blood Flow; Skin | 1987 |
Mitochondrial ring-phenomenon of keratinocytes in psoriasis vulgaris after dithranol therapy.
Topics: Anthralin; Epidermis; Humans; Keratins; Microscopy, Electron; Mitochondria; Psoriasis | 1987 |
Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
Topics: Adult; Animals; Anthralin; Cells, Cultured; Epidermal Cells; Female; Guinea Pigs; Humans; Keratins; | 1987 |
Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis.
Topics: Anthralin; Calcium; Cell Differentiation; Cell Division; Densitometry; Electrophoresis, Polyacrylami | 1989 |
Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens.
Topics: Anthralin; Densitometry; Electrophoresis; Epidermis; Etretinate; Female; Gene Expression; Humans; Hy | 1989 |
Plasminogen activation in psoriasis.
Topics: Adult; Anthralin; Betamethasone Valerate; Biopsy; Female; Humans; Immunoenzyme Techniques; Male; Mid | 1989 |
[The irritant effect of dithranol using capillary resistance measurement].
Topics: Adult; Anthralin; Clemastine; Drug Eruptions; Female; Humans; Indomethacin; Male; Middle Aged; Psori | 1989 |
Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
Topics: Anthralin; Calcium-Transporting ATPases; Calmodulin; Epidermis; Erythrocyte Membrane; Humans; Kerati | 1989 |
Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Administration, Cutaneous; Adult; Anthralin; Arachidonic | 1989 |
Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
Topics: Adult; Aged; Anthralin; Female; Humans; Male; Middle Aged; Psoriasis; Time Factors | 1989 |
Outpatient treatment with short-contact dithranol. The impact of frequent concentration adjustments.
Topics: Adolescent; Adult; Aged; Anthralin; Female; Humans; Male; Middle Aged; Ointments; Outpatients; Psori | 1989 |
The use of dithranol.
Topics: Anthralin; Humans; Ointments; Psoriasis | 1989 |
Ditrastick combined with UVB. An alternative regimen for plaque psoriasis.
Topics: Anthralin; Combined Modality Therapy; Drug Compounding; Humans; Psoriasis; Ultraviolet Therapy | 1989 |
"Ditrawash"--a novel remover of dithranol (anthralin) for short contact therapy of psoriasis.
Topics: Anthralin; Excipients; Fluorescence; Humans; Psoriasis | 1989 |
[Experience in treating psoriasis patients with the preparation Ditrastic].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Dermatologic Agents; Drug Combinations; Drug | 1989 |
[Experience in the use of ditrastic in the therapy of psoriasis].
Topics: Adolescent; Adult; Anthralin; Drug Combinations; Humans; Middle Aged; Paraffin; Psoriasis; Sulfur | 1989 |
[Anthralin therapy of psoriasis--a retrospective study of 39 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthralin; Female; Humans; Male; Middle Aged; Ointments; | 1989 |
[Current treatment of psoriasis].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cyclosporins; Glucocorticoids; Humans; | 1989 |
[Urea and urea combinations in psoriasis].
Topics: Administration, Topical; Anthralin; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Ther | 1989 |
Unusual mitochondrial reaction in psoriatic keratinocytes.
Topics: Adult; Anthralin; Biopsy; Humans; Microscopy, Electron; Mitochondria; Psoriasis; Skin | 1988 |
[Ambulatory treatment of psoriasis].
Topics: Adrenal Cortex Hormones; Ambulatory Care; Anthralin; Humans; Psoriasis; PUVA Therapy; Retinoids; Tar | 1989 |
The effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis.
Topics: Administration, Topical; Anthracenes; Anthralin; Antigen-Presenting Cells; Clobetasol; Histocompatib | 1985 |
A 6-month dermal toxicity test with dithranol and butantrone in miniature swine.
Topics: Administration, Topical; Animals; Anthralin; Drug Eruptions; Drug Evaluation, Preclinical; Female; G | 1986 |
[Skin reaction to dithranol and its modification by the addition of tar (LCD)].
Topics: Anthralin; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Male; Middle Aged; Patch Tests; | 1987 |
[Effect of topical antipsoriatic agents on ATPase-positive epidermal Langerhans cells. Animal experiment studies].
Topics: Adenosine Triphosphatases; Animals; Anthralin; Coal Tar; Langerhans Cells; Mice; Mice, Inbred BALB C | 1987 |
[Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Anthralin; Anti-Inflammatory Agents; Arachidonate Lipoxy | 1985 |
Lipoxygenase products of arachidonic acid in human inflamed skin.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Anthralin; Arachidonic Acid; Arachidonic Acids; D | 1985 |
An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
Topics: Animals; Anthracenes; Anthralin; Calmodulin; Cattle; Coal Tar; Etretinate; Hydrocortisone; In Vitro | 1986 |
Phototherapy and dithranol treatment of psoriasis.
Topics: Anthralin; Phototherapy; Psoriasis | 1987 |
Plasma 5-S-cysteinyldopa as an index of melanogenesis.
Topics: Adult; Anthralin; Cysteinyldopa; Dihydroxyphenylalanine; Female; Hair Color; Humans; Male; Melanins; | 1988 |
[Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
Topics: Adult; Anthracenes; Anthralin; Coal Tar; Dose-Response Relationship, Drug; Drug Combinations; Drug E | 1985 |
Yellow hair discoloration due to anthralin.
Topics: Aged; Aged, 80 and over; Anthralin; Female; Hair Color; Hair Diseases; Humans; Psoriasis | 1988 |
[Modified dithranol minute therapy of psoriasis vulgaris].
Topics: Adolescent; Adult; Aged; Anthralin; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1988 |
Lack of additive effect of coal tar combined with dithranol for psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Coal Tar; Drug Synergism; Drug Therapy, Combination; Female; Hum | 1988 |
Active oxygen species and structure specificity of antipsoriatic anthrones.
Topics: Anthralin; Oxygen; Photochemistry; Psoriasis | 1988 |
[Senecioyldithranol and beta-carbethoxypropionyldithranol: synthesis and glucose-6-phosphate dehydrogenase inhibition of two new 10-acyl derivatives of the antipsoriatic, dithranol].
Topics: Anthralin; Chromatography, High Pressure Liquid; Glucosephosphate Dehydrogenase; Humans; Psoriasis | 1988 |
[Preparations for the external treatment of psoriasis].
Topics: Administration, Topical; Adult; Anthralin; Drug Combinations; Humans; Middle Aged; Paraffin; Psorias | 1988 |
Anthralin and tar with UVB increase epidermal cell proliferation in asebia mice.
Topics: Animals; Anthralin; Cell Division; Coal Tar; Epidermis; Female; Mice; Mice, Mutant Strains; Psoriasi | 1988 |
The management and mismanagement of psoriasis.
Topics: Adolescent; Anthralin; Coal Tar; Female; Humans; Male; Middle Aged; Psoriasis; PUVA Therapy | 1988 |
The treatment of psoriasis.
Topics: Anthralin; Coal Tar; Humans; Psoriasis | 1988 |
Treatment of psoriasis with a combination of dithranol and coal tar.
Topics: Anthralin; Coal Tar; Drug Therapy, Combination; Humans; Psoriasis | 1988 |
Evaluation of a therapeutic concentration of dithranol in the mouse-tail test.
Topics: Animals; Anthralin; Disease Models, Animal; Female; Male; Mice; Mice, Hairless; Psoriasis; Random Al | 1988 |
Oxidation of antipsoriatic 10-acyldithranol derivatives and dithranol to 1,8-dihydroxyanthraquinone.
Topics: Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Magnetic Resonance Spectroscopy; Oxidation | 1988 |
[Combination of etretinate and dithrocream for severe psoriasis].
Topics: Adolescent; Anthralin; Drug Therapy, Combination; Etretinate; Female; Humans; Ointments; Psoriasis | 1988 |
Validity of the 'bioassay' for thioredoxin-reductase activity.
Topics: Anthralin; Biological Assay; Humans; NADH, NADPH Oxidoreductases; Psoriasis; Skin; Thioredoxin-Disul | 1988 |
Treatment options for psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Coal Tar; Dermatologic Agents; Emollien | 1988 |
[Tritium-labeled dithranol with high specific activity].
Topics: Anthralin; Humans; Psoriasis; Skin; Tritium | 1987 |
Optimization of topical therapy of psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Humans; Hydrocortisone; Psoriasis; Ski | 1986 |
[Anthralin].
Topics: Animals; Anthralin; Chemical Phenomena; Chemistry; Humans; Psoriasis; Structure-Activity Relationshi | 1987 |
[What is established in the treatment of psoriasis?].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Etretinate; Glucocorticoids; Humans; M | 1987 |
[Effect of dithranol therapy on membrane, basement membrane and nuclear markers in psoriasis lesions].
Topics: Adult; Anthralin; Antibodies, Antinuclear; Basement Membrane; Female; Fluorescent Antibody Technique | 1987 |
The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin.
Topics: Anthracenes; Anthralin; Anthraquinones; Humans; In Vitro Techniques; Psoriasis; Skin Absorption | 1987 |
Time course and intensity of anthralin inflammation on involved and uninvolved psoriatic skin.
Topics: Adult; Aged; Anthralin; Edema; Female; Humans; Male; Middle Aged; Psoriasis; Skin; Time Factors | 1987 |
The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.
Topics: Adult; Aged; Anthralin; Chemotaxis, Leukocyte; Female; Humans; Male; Middle Aged; Monocytes; Neutrop | 1987 |
Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy.
Topics: Administration, Topical; Anthralin; Coal Tar; Drug Combinations; Erythema; Humans; Psoriasis; Ultrav | 1987 |
Dithranol: further investigations on the structure-activity-relationship. The new series of the 10-mono-alkyldithranol derivatives.
Topics: Anthralin; Chromatography, Thin Layer; Drug Stability; Humans; Oxidation-Reduction; Psoriasis; Skin; | 1987 |
[Local effect of the nonsteroidal anti-inflammatory drug indomethacin on psoriasis].
Topics: Administration, Topical; Anthralin; Humans; Indomethacin; Psoriasis; Salicylates; Salicylic Acid | 1987 |
Anthralin inhibition of intraepidermal pustule formation.
Topics: Anthracenes; Anthralin; Humans; Psoriasis | 1986 |
Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
Topics: Administration, Topical; Adult; Anthracenes; Anthralin; Biopsy; Female; Humans; Male; Mast Cells; Mi | 1986 |
[Hyperreactivity to dithranol--irritation or allergy?].
Topics: Anthracenes; Anthralin; Drug Hypersensitivity; Humans; Patch Tests; Psoriasis | 1986 |
[Potential factors influencing dithranol erythema].
Topics: Adult; Anthracenes; Anthralin; Erythema; Female; Humans; Male; Patch Tests; Psoriasis; Skin | 1986 |
A 'novel' action of anthralin.
Topics: Adult; Anthracenes; Anthralin; Female; Humans; Male; Middle Aged; Plasminogen Activators; Psoriasis; | 1986 |
Skin toxicity and cellular metabolism: in vitro models.
Topics: Anthralin; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Humans; Models, Biologica | 1986 |
[Effect of various kinds of tar and tar concentrations on anthralin erythema].
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Coal Tar; Dose-Response Relationship, Drug; Erythem | 1986 |
[Short treatment of psoriasis with anthralin (dioxyanthranol, cignolin)].
Topics: Administration, Topical; Ambulatory Care; Anthralin; Drug Administration Schedule; Humans; Psoriasis | 1986 |
[Short-term treatment with cignolin].
Topics: Administration, Topical; Anthralin; Dermatologic Agents; Drug Administration Schedule; Humans; Psori | 1986 |
Anthralin.
Topics: Anthralin; DNA Replication; Humans; Mitochondria; Psoriasis; Skin Pigmentation; Time Factors | 1986 |
Irritant potential of dithranol.
Topics: Anthralin; Blister; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Incompatibility; Ery | 1986 |
Anthralin minute entire skin treatment: a follow-up and comparison with methoxsalen plus ultraviolet light.
Topics: Adult; Anthralin; Female; Humans; Male; Methoxsalen; Middle Aged; Psoriasis; PUVA Therapy | 1987 |
Reduction of anthralin inflammation by potassium hydroxide and Teepol.
Topics: Adolescent; Adult; Aged; Anthralin; Dermatitis; Fatty Alcohols; Female; Humans; Hydroxides; Male; Mi | 1987 |
A paired comparison of cream and ointment-based dithranol in short contact treatment of psoriasis.
Topics: Adult; Aged; Anthralin; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1987 |
Short-contact anthralin therapy for psoriasis using an aqueous cream formulation.
Topics: Adult; Aged; Anthralin; Female; Humans; Male; Middle Aged; Psoriasis; Time Factors | 1987 |
Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
Topics: Animals; Anthracenes; Anthralin; Chickens; Free Radicals; Humans; In Vitro Techniques; Lipid Peroxid | 1985 |
Detection of anthralin in skin during treatment.
Topics: Administration, Topical; Adult; Aged; Anthracenes; Anthralin; Borates; Humans; Microscopy, Fluoresce | 1985 |
Treatment of psoriasis. Results achieved by the Johannesburg Hospital Psoriasis Clinic.
Topics: Adult; Aged; Anthralin; Coal Tar; Etretinate; Female; Humans; Male; Methotrexate; Middle Aged; Psori | 1986 |
Short contact anthralin in the treatment of psoriasis: a study of different contact times.
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Chronic Disease; Color; Drug Administration | 1986 |
Woronoff ring during anthralin therapy for psoriasis.
Topics: Anthracenes; Anthralin; Erythema; Humans; Middle Aged; Pigmentation Disorders; Psoriasis; Skin | 1986 |
[A new treatment of outpatient psoriasis: short-term dithranol therapy].
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Female; Humans; Male; Middle Aged; Psoriasis; Time | 1986 |
Short-contact dithranol therapy.
Topics: Anthracenes; Anthralin; Drug Administration Schedule; Humans; Psoriasis; Statistics as Topic | 1986 |
[Dithranol and combined treatment procedures: pro and con].
Topics: Anthracenes; Anthralin; Combined Modality Therapy; Drug Therapy, Combination; Glucocorticoids; Human | 1985 |
["Minute therapy" of psoriasis with dithranol and its modifications. A critical evaluation based on 315 patients].
Topics: Anthracenes; Anthralin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy | 1985 |
[Tar treatment of psoriasis].
Topics: Anthralin; Combined Modality Therapy; Drug Therapy, Combination; Humans; Psoriasis; Radiotherapy Dos | 1985 |
[Distribution of dithranol therapy in dermatologic clinics and specialty practice in Switzerland].
Topics: Administration, Topical; Anthracenes; Anthralin; Anti-Inflammatory Agents; Dermatology; Drug Utiliza | 1985 |
[Reduction of the UV dose in combined dithranol-UV therapy of psoriasis].
Topics: Anthracenes; Anthralin; Combined Modality Therapy; Humans; Psoriasis; Radiotherapy Dosage; Ultraviol | 1985 |
Experimental contribution to the dithranol-brown problem.
Topics: Anthracenes; Anthralin; Anthraquinones; Hot Temperature; Humans; Mass Spectrometry; Psoriasis; Skin | 1985 |
Clinical signs of response to treatment in psoriasis--a cell kinetic and histological assessment using the IBAS II image analyser.
Topics: Aged; Anthracenes; Anthralin; Cell Division; Female; Humans; Male; Middle Aged; Psoriasis; Skin; Tel | 1985 |
[Short-term anthralin therapy as an interim therapy].
Topics: Ambulatory Care; Anthracenes; Anthralin; Drug Administration Schedule; Humans; Psoriasis | 1985 |
[Reiter syndrome].
Topics: Anthralin; Arthritis; Arthritis, Reactive; Conjunctivitis; Doxycycline; Humans; Middle Aged; Mustard | 1985 |
Anthralin cream as short contact therapy for psoriasis.
Topics: Administration, Topical; Anthracenes; Anthralin; Anti-Inflammatory Agents; Dosage Forms; Drug Evalua | 1985 |
[Topical treatment of psoriasis].
Topics: Administration, Topical; Anthracenes; Anthralin; Anti-Inflammatory Agents; Combined Modality Therapy | 1985 |
Comparison of the short-duration dithranol and Dithrocream therapy in the treatment of psoriasis.
Topics: Administration, Topical; Anthracenes; Anthralin; Humans; Ointments; Petrolatum; Psoriasis; Time Fact | 1985 |
Treatment of psoriasis in general practice with short contact dithranol.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Family Practice; Fe | 1985 |
Short-contact therapy.
Topics: Animals; Anthracenes; Anthralin; Humans; Kinetics; Ointments; Psoriasis; Skin Absorption; Time Facto | 1985 |
Anthralin therapy for psoriasis. A new look at an old compound.
Topics: Anthracenes; Anthralin; Humans; Psoriasis; Time Factors | 1985 |
[Short-term treatment of psoriasis vulgaris with dithranol with added urea].
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Child; Drug Combinations; Female; Humans; Male; Mid | 1985 |
The day-care centre in the management of psoriasis.
Topics: Ambulatory Care; Anthralin; Day Care, Medical; Etretinate; Humans; Psoriasis; PUVA Therapy | 1985 |
The treatment of psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antineoplastic Agents; Coal Tar; Etret | 1985 |
[Reduction of erythema by the addition of bituminous coal tar in anthralin short-term therapy].
Topics: Adolescent; Adult; Aged; Anthracenes; Anthralin; Coal Tar; Drug Therapy, Combination; Erythema; Fema | 1985 |
[Suitability of the metal halogenide radiation source NS 1000-76 for SUP therapy].
Topics: Anthralin; Combined Modality Therapy; Humans; Psoriasis; Ultraviolet Therapy | 1985 |
[Suppression of dithranol erythema by the addition of tar in short-term therapy].
Topics: Anthracenes; Anthralin; Drug Therapy, Combination; Erythema; Humans; Psoriasis; Tars | 1985 |
[A new UV-B irradiation unit. Experiences with psoriasis vulgaris with low dosage UV-B irradiation and local cignoline use].
Topics: Administration, Topical; Adolescent; Adult; Anthracenes; Anthralin; Combined Modality Therapy; Dose- | 1985 |
Ultrastructural changes in psoriatic epidermis following anthralin treatment.
Topics: Adult; Anthracenes; Anthralin; Basement Membrane; Cell Membrane; Cytoplasmic Granules; Female; Human | 1974 |